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CHAPTER 1 
1.1 INTRODUCTION 
In medicine, adhesion is the growing together of normally separated surfaces by 
fibrin, which is later organized as fibrous tissue 
In his foreword to "THE PROPHYLAXIS OF PERITONEAL ADHESIONS", 
published in Surgery in 1942, Boys stated that "the peritoneal adhesion has been recognized 
as a surgical entity for nearly 150 years, its enologie factors and pathologic characteristics 
have been understood for over 50 years, and, yet, no satisfactory major prophylaxis has been 
developed" (1) Fifty years on, in 1993, this same statement is still valid What is more, it 
is no longer held that etiological factors are understood, at least not completely 
During ancient and mediaeval times many symptoms were recognized but only one 
abdominal disease By the time of the Renaissance differentiation was made between three 
"belly passions" The acute abdomen was not longer considered as a single disease with 
many symptoms, on the contrary, it was recognized that different diseases may occur (1) 
John of Goddesden in the Rosa Anglica in 1314 recorded a clinical differentiation between 
the renal passion, the calculous kidney colic, the iliac passion, peritonitis and the colic 
passion The latter signifying intestinal obstruction, as we know now, frequently caused by 
peritoneal adhesions (2) 
In 1761, Morgagni m DE SEDIBUS ET CAUSIS MORBORUM described the first 
complete account of lesions based on postmortem examinations, correlated with the clinical 
history of the patient Shortly thereafter, peritoneal adhesion was described as a true disease 
entity for the first time John Hunter (1728-1793), a London surgeon and anatomist, 
meticulously described the manifest aspects of adhesions and attributed these to peritonitis 
He named the sticky substance holding the bowel surfaces together "gluten" (1) In 1802, 
Mane François Xavier Bichat (177Ы802), a French physician, published his famous work 
on peritonitis and its resulting adhesions. 
The nineteenth century saw both an increasing incidence of autopsies and 
improvements in the microscope which allowed the causes of peritonitis to be studied in 
greater detail Further, puerperal fever, appendicitis, subphrenic abscess, gastrointestinal 
perforations, pelvic inflammatory disease or cholecystitis were described as separate causes 
of peritonitis and producers of adhesions (1,2) In the second half of the nineteenth century, 
with the birth of bacteriology and the improvement of surgical techniques, it became possible 
to observe the course of abdominal disease and to identify bacteria. One of the earlier 
references to operative lysis of adhesions was mentioned by Carson (2). In 1859 Brinton, 
Physician to the Royal Free Hospital in London, discussed an operation for intestinal 
obstruction caused by twists and bands (1,2,3). 
At the beginning of this century Richardson (1911) described the process of 
intraperitoneal adhesion formation, a description which is still valid today (4): 
- injury or death of the surface endothelium, 
- pouring out of coagulable exudate, 
- agglutination, 
- organization, 
- fibrous tissue formation, which terminates ultimately in, 
- a contracted scar. 
He classified the various agents, summarizing the literature concerning the etiology of 
adhesions and factors, and identified the causes of adhesions: blood, sutures and ligatures, 
eschar of the thermocautery, exposure to air, infection, mechanical, chemical and other 
agents. 
Research on the prevention of the formation or reformation of peritoneal adhesions 
dates from the end of the nineteenth century. In the literature we find a widespread interest 
in the subject of adhesion prevention; this was probably caused initially by the increasing 
number of patients who underwent abdominal surgery with the rising incidence of 
postoperative intestinal obstructions due to adhesions. Boys (1942) summarized the measures 
of adhesion prevention by limiting peritoneal injury through (1): 
- scrupulous aseptic technique, 
- gentle handling of tissue, 
- accurate, prompt haemostasis with minimal tissue devitalization, 
- avoidance of intraperitoneal use of chemical solutions, 
- avoidance of thermal injury, 
- avoidance of leaving behind in the peritoneal cavity unnecessary foreign bodies, such as 
long suture ends, unneeded drains, sponges etc. 
All these measures are still of great importance today. They are the basis of the atraumatic 
microsurgical techniques currently applied to prevent adhesions (5). In his review of the 
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literature Boys described four other "fundamental attacks to be directed towards adhesion 
prevention" 
- to prevent coagulation of the serous exudate, 
- to remove or dissolve deposited fibrin, 
- to keep the fibrin-coated peritoneal surfaces apart until mesotheliahzation has occurred, 
- to inhibit fibroblastic proliferation 
Research on adhesion prevention over the most recent decades, as well as current 
research, concentrated on the area of these five "fundamental attacks" 
Research on the formation and prevention of adhesions has been performed for more 
than a century by abdominal surgeons Adhesions are known to impair fertility, while 
potential improvements in fertility are made possible by reconstructive surgical procedures 
in the female pelvis For these reasons gynaecologists have shared with surgeons their 
interest in adhesion formation and prevention 
Since the sixties we have known that the fibrinolytic capacity ot peritoneum is 
important in resorption of fibrinous adhesions (6) Impairment of the fibrinolytic activity by 
peritoneal injury or inflammation prevents resorption ot the early fibrinous adhesions, so that 
these may become organized by fibroblastic prolileration resulting in permanent adhesions 
(7,8) Research is, thereiore, currently being performed in the field of fibrinolysis in relation 
to adhesion formation and prevention 
Over the last century hundreds ot papers have been published on aspects of adhesion 
formation and especially about the prevention ot adhesions In spite of the enormous amount 
of work which has been carried out, we still do not know all the etiological aspects of 
adhesion formation and it is still not possible to prevent these adequately Basic research is 
needed to identify and explain the mechanisms of adhesion formation and, using this 
knowledge, to achieve better methods tor adhesion prevention 
1.2 OBJECTIVES AND OLTLINE OF THE TMESIS 
The principal aim of this study is to acquire a better understanding of the pathogenesis 
of adhesions 
First, a review of the literature is given in particular with regard to the clinical 
relevance of adhesions in women The relationship between adhesions and pain, intestinal 
obstruction and infertility is evaluated Current knowledge of the pathogenesis of adhesions 
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is summarized and the more recent literature about prevention of adhesions is discussed. A 
synopsis is given of fibrinolysis and fibrinolytic assays, especially for the reader who is not 
acquainted with fibrinolysis. 
Fibrinolytic parameters in the peritoneal fluid and plasma of healthy women in the 
first and second part of the menstrual cycle are analysed. The fibrinolytic parameters in 
peritoneal fluid and plasma of women with pelvic inflammatory disease (PID) and 
endometriosis are determined in order to gain more insight into the process of adhesion 
formation in these conditions. 
Final objective of this thesis is to present results on the prevention of post-operative 
intraperitoneal adhesions by tissue-type plasminogen activator (t-PA) in an experimental 
model in the rabbit. A morphological study is performed to study mesothelial healing with 
and without t-PA treatment and to describe the origin of new mesothelium in the same 
experimental rabbit model. 
In the last chapter the conclusions are summarized of the investigations described. The 
pathogenesis of adhesions is discussed with reference to the information acquired through our 
research. 
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CHAPTER 2 
2.1. PREVALENCE OF ADHESIONS 
Studies on the prevalence of adhesions are based on data gathered either from 
repeated laparotomies or from autopsies. 
The only way to establish the prevalence of intraperitoneal adhesions is by means of 
autopsies, since this is the only possibility that affords complete exploration of the peritoneal 
cavity. For this reason, studies based on relaparotomy findings are not included in our 
review. Some publications will be discussed, in which the prevalence of adhesions is 
established through laparotomies, to give us an idea about their prevalence after 
gynaecological laparotomies. 
Diebold (1930) studied adhesions in 700 autopsies (1). In 232 (33%) cases he found 
adhesions. He noticed an increase of adhesions with an increase of age. There was no 
difference in prevalence of adhesions between men and women. Benzer et al. (1963) looked 
for adhesions in 303 autopsies. In 136 (44.9%) autopsies they found adhesions, but in those 
without a history of laparotomy the frequency was 29.5%; when there was a laparotomy in 
the history this frequency was 71.8% (2). 
In a detailed report of Weibel and Majno (1973) on the prevalence of adhesions based 
on the findings in 752 autopsies, the percentage of adhesions was 44.5%. Adhesions were 
present in 67% of cases who had undergone laparotomy and in 28% of those who had not. 
Age and sex did not influence the prevalence of adhesions. With regard to constitutional 
factors, short, obese women were especially prone to postoperative adhesions. In men, 
constitutional factors were not found to affect the prevalence of adhesions. The prevalence 
after minor (e.g. appendectomy), major (e.g. cholecystectomy, aortic bypass) and multiple 
operations was 51, 72 and 93% respectively. Postoperative adhesions were, of course, mostly 
concentrated around the site of operation. The omentum was involved more than any other 
organ, followed by the large intestine, the small intestine, liver, spleen and female genital 
organs. A selection of data as mentioned is given in Table 2.1. 
The only study, giving detailed information of adhesions after gynaecological 
laparotomies, is that of Turunen (4). His data are based on observations made at repeated 
laparotomies. He found adhesions in 86.9% of patients with a history of gynaecological 
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laparotomies. In 271 patients with adhesions the omentum was involved in 56.8%, the small 
intestine in 20.7%, the colon in 18.8% and the rectum in 3.7% of the number of cases. In 
73 patients with adhesions after appendectomy, the omentum was involved in 45.2%, the 
colon in 46.6%, the small intestine in 5.5% and the right tube and ovary in 2,7%. In 1966, 
Swolin summarized the literature for the prevalence of postoperative adhesions after 
gynaecological laparotomies and found adhesions in 73-91% of the patients at the time of a 
relaparotomy (5). 
To conclude, studies based on autopsies show us that in 33-45% of cases adhesions 
are found. The percentage of adhesions is significantly higher in the group with a history of 
laparotomy (67-72%) than in the group without laparotomies (28-29%). We should bear in 
mind, of course, that among cases with prior surgery a certain percentage of adhesions may 
not have been caused by surgery (3). 
TABLE 2.1 Prevalence of intraperitoneal adhesions established by autopsies in patients 
(pat) with and without a laparotomy (lapt) in the history 
Author 
Diebold (1) 
Benzer (2) 
Weibel (3) 
Number of 
Autopsies 
700 
303 
752 
Number/% 
Adhesions 
232/33% 
136/44.9% 
335/44.5% 
% pat with 
Adhesions 
+ lapt 
no data 
71.8% 
67% 
% pat with 
Adhesions 
- lapt 
no data 
29.5% 
28% 
2.2 ADHESIONS AND PAIN 
Do adhesions cause pain? This question is difficult to answer. In the literature, 
attempts have been made to answer this question using data obtained by diagnostic 
laparoscopics. In 25-50% of patients with chronic pain, pelvic adhesions were found 
(6,7,8,9). The subjective location of pain was found to correlate well with the anatomical 
location of adhesions, but there was no relationship between the extent of adhesions and the 
severity of chronic pelvic pain (10). 
A review of the literature aimed at providing a conclusive answer to the problem of 
adhesions and pain shows contradictory opinions. Some authors suggest a relationship 
between adhesions and pain (6,7,11,12). The only study involving a control group is from 
Kresch et al., who evaluated 100 women with chronic pelvic pain and compared this group 
with 50 asymptomatic women who underwent laparoscopy for tubal ligation (7). Overall, 
83% of the pain group had pelvic pathology (adhesions and/or endometriosis) as compared 
with 29% of the asymptomatic group. Adhesions were the most common pathological 
findings accounting for 51 % in the group with pelvic pain compared with 14% in the control 
group. Other authors found adhesions to be equally frequent in patients with and without pain 
and discarded a relation between adhesions and pain (9,13). 
When there would be a relationship between adhesions and pain, adhesiolysis should 
result in the relief of abdominal pain and complaints about pain should return with 
reappearance of adhesions. 
In several studies, the impact of lysis of abdominal adhesions on pain relief has been 
evaluated (12-18). All these studies show relief of pain after lysis of adhesions. Steege and 
Stout evaluated prospectively thirty women with chronic pelvic pain after laparoscopic lysis 
of adhesions (19). They showed that in short-term follow-up the majority (88%) reported 
relief of pain and that a quarter noted the return of pain within three to five months. Some 
studies suggested that adhesions involving large or small bowel, resulting sometimes in 
"Subileus" (a temporarily disturbance of progression of intestinal contents) may cause 
abdominal pain and that patients with these adhesions may derive benefit from lysis of 
adhesions (16,19). The only prospective randomized study of lysis of adhesions for the 
benefit of pain relief showed that lysis was of little value (16). Peters et al. compared a 
group of 24 women with pain and laparoscopically-confirmed adhesions, in whom lysis of 
adhesions by laparotomy was performed, with 24 women with pain and the same adhesion 
scores, in whom no laparotomy was performed. After a follow-up period of nine to twelve 
months there was no difference in pain scores between the two groups, although women with 
dense vascularized adhesions involving the intestines reported some improvement after 
laparotomy. 
Studies on pain show the complexity of chronic pain problems (16,20). Early theories 
hypothesized specific pain receptors and neurons and suggested that pain was only a reaction 
to tissue damage (21). Newer theories of pain perception such as the "Gate Control Theory" 
and cognitive behaviourial models integrate the influences of culture, personality, stress, 
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organic changes, etc (22,23). These models avoid a demarcation between physical and 
psychological causes of pain and recognize their interdependence. 
The question "do adhesions cause pain?", therefore, is not simple to answer. Some 
studies show a clear relationship between adhesions and pain, other studies deny such a 
relationship. Most studies are purely "somatic" and do not consider integrated pain models. 
2.3 ADHESIONS AND INTESTINAL OBSTRUCTION 
During the past century and at the beginning of this century, intestinal obstruction was 
mainly caused by hernias. After World War II in the developed countries, adhesions have 
replaced hernias as the most common cause of intestinal obstruction due to an increasing 
number of abdominal operations and the fact that most hernias are repaired before 
complications may occur. At the beginning of this century hernias were responsible for 
around 45% of bowel obstructions, while adhesions accounted for at most 30% (24-26). 
Since the fifties adhesions have been found to be the principal cause of bowel obstruction, 
up to 74% of cases, and hernias less frequently, less than 25% (27-32). 
Menziez and Ellis studied the incidence of hospital admissions for adhesive intestinal 
obstruction (33). Over a 25-year period 261 of 28.297 adult general surgical admissions were 
for intestinal obstruction from adhesions (0.9%). Of 4502 laparotomies, 148 were for 
adhesive obstruction (3,3%). Shikata et al. showed in a nationwide questionnaire of intestinal 
obstruction in Japan that the incidence of admissions for adhesive bowel obstruction is rising. 
Obstructions caused by adhesions increased from 42.5% in 1975/76 to 60.8% in 1985/86 
(34). 
The majority of patients with intestinal obstruction caused by adhesions have a history 
of laparotomy. In other patients, adhesions leading to bowel obstruction are caused by 
inflammation. In some patients, no specific causes are found for adhesions; these are so-
called congenital adhesions or bands. 
In patients with adhesive intestinal obstruction, 79-90% had previous abdominal 
surgery (27,28,29,31,35). Appendectomy (18-38%) and gynaecological operations (23-34%) 
are the most frequent operations in the history of patients with adhesive intestinal obstruction 
(27,29,31,35). 
Adhesive bowel obstruction usually affects the small bowel only (28,35). In particular 
after appendectomy, gynaecological operations and colon surgery the ileum is involved in 
adhesion formation (36). Obstruction of the large bowel caused by adhesions is rare. 
Intestinal obstruction caused by adhesions is more common in women than in men, 
but if adhesions following gynaecological operations are excluded, the sex distribution is 
almost equal (29,35). 
In his group of 1477 patients with intestinal obstruction due to adhesions, Räf studied 
the interval between the initial laparotomy and the operation for intestinal obstruction. In 
44% of the cases this interval was less than 5 years, in 17% more than 20 years, the longest 
interval was 56 years (29). The age of patients with adhesive bowel obstruction was between 
45 and 49 years on the average (28,29). 
The mortality rate in patients with adhesive intestinal obstruction is (still) high and 
varies between 5.9 and 11.8% (27,28,29,31,35). 
2.4 ADHESIONS AND INFERTILITY 
The importance of periadnexal adhesions in women as a cause of infertility is widely 
recognized. Adhesions may interfere with ovum pick-up and transport, sperm transport and 
zygote transfer. 
Only a few studies have evaluated the influence of periadnexal adhesions on the pregnancy 
rate following surgery. These suggest an inverse relationship between periadnexal adhesions 
and pregnancy rates. The major causes of pelvic adhesions in women are infection, pelvic 
surgery and endometriosis. All three may impair fertility, not only by the ensuing adhesions, 
but also by damage to the interior of the fallopian tubes and changes in peritoneal 
environment. 
Table 2.2 gives a summary of the data on studies for pregnancy and delivery rates 
following lysis of pelvic adhesions (37-42). In almost all patients infertility was due solely 
to periadnexal adhesions. Pregnancy rates varied between 32 and 63%, delivery rates 
between 24 and 57%. None of the studies mentioned had a control group of infertile women 
with periadnexal adhesions, but without laparotomy. Some studies showed an inverse 
correlation between the extent of periadnexal adhesive disease and pregnancy rates with more 
pregnancies in the low grade adhesion groups comparing the high grade groups 
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(38,39,40,42). Other studies did not find a correlation between the extent or grades of 
adhesions and pregnancy rates (37,41). 
The surgical outcome of tubal microsurgery is influenced by the extent of pelvic 
adhesive disease. The success rate of salpingostomy is also inversely proportional to the 
extent of pelvic and periadnexal adhesions (42-45). 
The American Fertility Society (AFS) published a standard classification scheme for 
mechanical problems associated with infertility and fetal wastage (46). The AFS classification 
of adnexal adhesions differentiates between minimal, mild, moderate, and severe adhesions. 
A differentiation is made between filmy and dense adhesions. The prognosis for conception 
is based on the score applied for the adnexa with the least amount of pathology. For future 
study, it is important that only one international classification scheme of adnexal disease is 
adopted and used, e.g. the AFS classification scheme. The studies mentioned above used 
different adhesion scores which are hard to compare. The use of only one classification 
scheme will enable the evaluation and comparison of the outcome of different therapies 
concerning lysis of adhesions and adhesion prevention. 
TABLE 2.2 Pregnancy and delivery rates following lysis of pelvic adhesions 
Author 
Young (37) 
Jessen (38) 
Branson (39) 
Caspi (40) 
Diamond (41) 
Hulka (42) 
Number of 
Patients 
47 
45 
35 
42 
360 
47 
Pregnancy 
Rate 
η 
18 
17 
22 
18 
161 
15 
(%) 
(38) 
(38) 
(63) 
(43) 
(45) 
(32) 
Delivery 
Rate 
η (%) 
15 (32) 
11 (24) 
20 (57) 
no data 
135 (38) 
12 (26) 
2.5 PATHOGENESIS OF ADHESIONS 
Richardson described the process of adhesion formation at the beginning of this 
century (47). His concept of the sequence of events is still valid today and is described in 
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paragraph 1.1. Not every peritoneal injury results in a permanent fibrous adhesion. Ellis 
stated in 1962: "the crucial point is the factor which determines whether fibrin (in the 
coagulable exudate) is absorbed or is converted into fibrous tissue" (48). 
Peritoneal injury results in an inflammatory response from the serosal surfaces with 
outpouring of a serofibrinous exudate. This exudate coagulates within three hours (49). The 
majority of the early fibrinous adhesions are transient and are lysed and absorbed within 72 
hours (50). Some fibrinous adhesions may persist, however, and become organized to fibrous 
collagenous adhesions. 
Macroscopical healing of injured peritoneum is completed within five to seven days 
(51,52). Light microscopical studies in several animals show that a fibrinous exudate may 
persist until 48 hours after peritoneal injury. After three to four days the fibrinous exudate 
is absorbed and fibroblast proliferation is seen. Bundles of collagen are present after five 
days (51-55). After three to eight days the peritoneal wound is covered by a continuous layer 
of cells which resemble normal mesothelium (52,53). 
In 1962 Ellis proposed a hypothesis that tissue ischemia is the important factor in the 
etiology of fibrous adhesions (48). He remarked that adhesions did not represent scar tissue, 
but vascular grafts from adjacent healthy organs into a devascularized substrate. Until then 
the generally-accepted view of the etiology of fibrous adhesions was that their formation 
depended on the integrity of the peritoneum. The injured peritoneum would pour out fibrin 
resulting in fibrinous adhesions between adjacent surfaces. If the peritoneum was intact, the 
fibrin would be reabsorbed; if it had been damaged, fibroblasts invaded the fibrin and fibrous 
adhesions would develop. Following this concept of adhesion formation, it was widely taught 
that damage to the peritoneum must be avoided and serosal defects carefully repaired to 
prevent adhesions. It is remarkable that von Dembowski in 1888 and Franz in 1902 already 
had shown that defects of parietal peritoneum often heal without adhesions (56,57). 
Data from a number of investigators have shown that peritoneum which has been 
made ischemic loses its spontaneous ability to lyse fibrin. Benzer et al. (1963) first 
demonstrated fibrinolytic activity in human peritoneum (2). The occurrence of lysis in fibrin 
plates indicates that mesothelial surfaces possess a fibrinolytic activator able to convert 
plasminogen to plasmin which causes fibrinolysis. Myhre-Jensen et al. (1969) and Porter et 
al. (1969) confirmed this finding and suggested that mesothelial fibrinolytic activity could 
play an essential role in fibrin resorption from mesothelial lined spaces (58,59). Porter et al. 
(1971) found that mechanical abrasion of human mesothelium produced an average reduction 
of 25% in fibrinolysis induced by the bare peritoneum upon fibrin plates (60). They 
suggested that reduction of mesothelial fibrinolytic activity could explain the occurrence of 
postoperative adhesions. 
Plasminogen activator activity (PAA) is located in the mesothelium and in the 
submesothelial blood vessels (60-62). Merlo et al. (1980) demonstrated differences in PAA 
in different areas of human peritoneal serosa. Among the areas studied, PAA was found to 
be highest in the omentum majus (61). 
Gervin et al. (1973) reported experimental evidence in dogs that a decrease in 
fibrinolytic activity of more than 50%, caused by serosal abrasion, was associated with 
adhesion formation (62). Buckman et al. (1976) showed that different forms of peritoneal 
injury in the rat exerted its effect on peritoneal fibrinolysis for three to four days (63). The 
time lapse of the return of PAA varied with different forms of injury. A comparison was 
made of PAA of raw peritoneal defects and peritoneal grafts. Peritoneal grafts were shown 
to suffer a significant and prolonged depression of fibrinolytic activity (up to 96 hours). 
Deperitonealized surfaces showed no suppression of PAA. Biopsies of free peritoneal grafts 
prevented fibrinolysis by normal peritoneum. Biopsies of deperitonealized areas significantly 
increased fibrinolytic activity of normal peritoneum. The low in vitro fibrinolytic activity and 
the release of inhibitor by peritoneal grafts was associated with persistence in vivo of 
fibrinous adhesions to the grafts at 96 hours and fibrous adhesion formation at two weeks. 
The normal in vitro fibrinolytic activity and the increase in fibrinolysis in biopsies from 
deperitonealized areas was associated with the in vivo disappearance of fibrinous adhesions 
to these areas by 96 hours and the absence of fibrous adhesions after two weeks. They 
concluded that peritoneum which has been made ischemic by grafting or tight suturing not 
only loses its ability to lyse fibrin, but may actively inhibit fibrinolysis by normal tissues. 
Raftery confirmed the findings of Buckman et al. (64-66). After peritoneal injury fibrinolytic 
activity is lowest at 24 hours and increases until the eighth day when peritoneal heating is 
complete. 
Ryan et al. (1971) described an experimental model of peritoneal adhesions in the rat 
based on two peritoneal accidents commonly occurring during surgery: drying of the serosa 
and contact with blood. Drying alone was the least effective in producing adhesions. Fresh 
blood introduced into the peritoneal cavity always formed a clot. In the absence of previous 
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serosal injury fresh blood did not consistently cause adhesions. When the volume of blood 
was larger the incidence and extent of adhesions increased. However, when blood was 
combined with drying, adhesions were consistently induced. Plasma alone did create fibrinous 
attachments on dried areas, but most of these disappeared within a few days. Heparinized or 
defibrinated blood were ineffective in producing adhesions to dried areas, indicating that 
fibrin is essential for adhesion formation (67). Nisell and Larsson confirmed these 
observations (68). Ryan et al. explained the great effectiveness of drying plus bleeding by 
two sources of fibrin: the exudate and the blood clot. They concluded by stating that "fibrin 
is essential for providing the initial bridge between the two surfaces; when the bridge is made 
by fibrin only, it will soon be cut by fibrinolytic mechanisms, but when it contains, with the 
fibrin, also cellular elements (erythrocytes, leucocytes, platelets), it will be anchored and 
stabilized by the ingrowth of granulation tissue". Hau et al. (1979) demonstrated in the dog 
that a standard laparotomy decreased fibrinolytic activity of tissue homogenates of normal 
peritoneum by almost one half (69). 
Besides a decrease in fibrinolytic activity of peritoneum following laparotomy, the 
fibrinolytic activity of peritoneal macrophages is depressed after surgery (70). In the early 
period of peritoneal repair after surgical injury, polymorphonuclear leucocytes and fibrin are 
the most pronounced elements of the inflammatory reaction. Subsequently, the 
polymorphonuclear leucocytes disappear and the number of macrophages increases (52). 
Orita et al. have shown that the PAA of rabbit macrophages, recovered from peritoneal fluid 
three to four days after surgery, was generally greater than the PAA of peritoneal 
macrophages recovered on the first or second postoperative day; on the tenth postoperative 
day a sixfold increase of PAA was detected (70). 
The association between endometriosis and infertility is seen clearly in extensive 
endometriosis, when adhesions impair ovarian physiology and tubal ovum pick-up. The 
etiology of adhesions in endometriosis remains unclear. Conflicting data about the etiology 
of adhesions in endometriosis have been presented in the literature. 
Ohtsuka (1980) found that PAA in endometriotic implants was decreased in 
comparison with PAA in normal peritoneum in the same patients (71). Àstedt and 
Nordenskjöld (1984) found increased concentrations of the plasminogen activators, tissue-type 
plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-ΡΑ) in peritoneal 
fluid of patients with endometriosis. Fibrinolytic activity of peritoneal fluid, determined on 
fibrin plates, was the same in women with endometriosis as in patients with no evidence of 
endometriosis (72). Malick (1982) showed that serosal PAA in one patient with endometriosis 
was low compared with serosal PAA of 14 patients with no evidence of endometriosis (73). 
Both Pattinson et al. and Batzofin et al. did not find any difference in peritoneal fluid PAA 
comparing women with endometriosis and control patients (74,75). Dunselman et al. 
confirmed these findings (76). They measured the concentrations of plasminogen, fibrinogen, 
Qf2-antiplasmin, a2-macroglobulin, t-PA, plasminogen activator inhibitor (PAI) and fibrin 
degradation products in women with and without endometriosis and did not find significant 
differences in any of these parameters. 
In conclusion, the etiology of adhesions in endometriosis is not clear. 
Peritonitis of infectious origin is associated with adhesion formation. The mechanisms 
by which infection induces adhesions have not been clarified. 
Hau et al. (1979) found in the dog that bacterial peritonitis almost suppressed 
fibrinolytic activity of the peritoneum (69). Chapman et al. (1983) demonstrated that 
endotoxin modified PAA of stimulated mouse macrophages in vitro (77): overall PAA of 
macrophages stimulated by endotoxin was lower. This was due in part to the secretion of PAI 
by endotoxin-stimulated macrophages. They found that after intraperitoneal endotoxin 
injection in the mouse, ascitic fluid lost its fibrinolytic activity and became strongly anti-
fibrinolytic. 
In response to tissue injury, cytokines are synthesized and released by infiltrating 
cells, e.g. macrophages (78). Intcrleukin-1 (IL-1) and tumor necrosis factor (TNF) play a 
role in the process of adhesion formation. The production of IL-1 and TNF by e.g. 
macrophages is induced by toxins, injury and inflammation. As well as having systemic 
effects when they have access to the circulation, cytokines exert local effects, e.g. on the 
vascular endothelium and mesothelial cells. IL-1 and TNF increase the production of PAI and 
u-ΡΑ in human endothelial cells in vitro. The production of t-PA is unaffected or decreased 
(79,80). In vitro, human omental mesothelial cells produce t-PA and PAL TNF induces a 
decrease of fibrinolytic activity in these cells by a decrease of t-PA and an increase of PAI 
(81). In this way, cytokines may interfere with PAA of endothelial and mesothelial cells and 
influence adhesion formation. This is in agreement with the conclusions of Hershlag et al. 
(1991), who showed that IL-1 enhanced the formation of adhesions in the rat (82). 
To conclude, intraperitoneal adhesions are caused by laparotomy, inflammation or 
endometriosis. First, fibrin is deposited in areas of mesothelial injury. When intraperitoneal 
fibrinolysis is inadequate the fibrinous clot is organized by fibroblastic proliferation and 
deposition of collagen resulting in permanent fibrous adhesions. In general, peritoneal 
injuries may cause a (temporary) decrease of peritoneal fibrinolysis. The impairment of the 
intraperitoneal fibrinolytic capacity is determined by several factors, such as the nature and 
degree of the peritoneal injury, the presence of activated macrophages, endotoxins and 
cytokines. All these factors influence the activators and inhibitors of intraperitoneal 
fibrinolysis, sometimes resulting in a certain decrease of fibrinolysis so that lysis of fibrinous 
adhesions is obstructed. This allows access to fibroblasts which penetrate the fibrinous clot 
resulting in permanent adhesions. 
2.6 FIBRINOLYSIS 
Fibrinolysis is the breakdown of insoluble fibrin into soluble fibrin degradation 
products. Breakdown of fibrin is caused mainly by plasmin. Plasmin exists in plasma in a 
precursor form, the zymogen plasminogen. Plasminogen is activated according to two major 
pathways, the t-PA and the u-ΡΑ pathway. The process of fibrinolysis is controlled by 
activators, which are serine proteases (the amino acid serine is located at their active site) 
and inhibitors, except for few serpins (serine protease inhibitors). 
The major components of the fibrinolytic system are discussed in the following paragraphs 
(see also Fig. 2.1) (83-90). 
Tissue-type plasminogen activator (t-PA) 
T-PA is synthesized and secreted mainly by endothelial cells as single-chain tissue-
type plasminogen activator (sct-PA). Release of t-PA from endothelial cells is induced by 
exercise, venous occlusion, mental stress and a number of chemical substances, among them 
bradykinin, (nor)adrenalin, thrombin, nicotinic acid and vasopressin or its analogue 
desmopressin (des-amino-D-arginine vasopressin, DDAVP). In the presence of plasmin, 
tissue kallikrein or factor Xa, sct-PA is converted into two-chain tissue-type plasminogen 
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activator (tct-PA). There are several functional differences between sct-PA and tct-PA, but 
in the presence of fibrin, sct-PA and tct-PA activate plasminogen equally well. In the absence 
of fibrin, sct-PA and tct-PA are poor activators of plasminogen. In the presence of fibrin, 
t-PA and plasminogen are attached to the fibrin, resulting in turnover rates which are 200 
to 400 times faster than those of fibrin-bound plasminogen. 
t-PA activity in plasma depends on its rate of release (mainly from endothelial cells), 
clearance (mainly by the liver) and the presence of protease inhibitors. The reaction rate of 
t-PA with its inhibitors alpha-2-antiplasmin, alpha-2-macroglobutin and antitrypsin is slow. 
In baseline conditions most of the t-PA in human plasma is complexed to Plasminogen 
Activator Inhibitor-1 (PAI-1) and only about 5% circulates in a free form. After enhanced 
release the free t-PA concentrations can be several times higher. PAI-1 is the most important 
inhibitor of t-PA, the reaction between t-PA and PAI-1 is fast. 
In man the circulatory half-life of t-PA is 3 to 10 minutes. 
Urokinase-type plasminogen activator (u-PA) 
A variety of cell types produce u-ΡΑ such as endothelial cells, epithelial cells, 
pneumocytes, decidual cells and stimulated mononuclear cells. While the main role of t-PA 
is believed to prevent extension of intravascular thrombi, u-ΡΑ is probably important in 
(modulation of) extracellular proteolytic mechanisms, resulting in increased vascular 
permeability, cellular migration, tumor invasion, tissue remodelling, fertilization, 
implantation and embryogenesis. 
Urokinase is produced by a variety of cultured cell types in the form of single-chain 
urokinase type plasminogen activator (scu-PA or pro-urokinase). Conversion of scu-PA to 
two-chain u-ΡΑ (tcu-PA or high molecular weight urokinase, HMW-UK) occurs in the 
presence of small amounts of plasmin. Contact activation of the coagulation system results 
in conversion of prekallikrein to kallikrein (induced by factor Xlla). Kallikrein converts scu-
PA to tcu-PA. This conversion is independent of plasmin. In this way the u-ΡΑ activator 
pathway becomes more efficient after contact activation. Scu-PA is considered to be an 
inactive proenzyme, it has little or no proteolytic activity against plasminogen, although it 
is possible that there are both active and inactive forms of scu-PA. Recombinant scu-PA 
activates plasminogen more efficiently than does tcu-PA. PAI-1 and PAI-2 react with tcu-PA 
but not with scu-PA. 
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Plasminogen Activator Inhibitor-1 (PAM) 
PAM or endothelial PAI was first detected in plasma and later in media of cultured 
endothelial cells. It is also produced by hepatocytes, hepatoma cells, fibrosarcoma cells, 
melanoma cells, human vascular smooth muscle cells, placenta extracts and extracellular 
matrix. 
PAI-1 reacts with sct-PA, tct-PAt tcu-PA, but not with scu-PA. Apart from PAM 
in plasma, PAI-1 also occurs in the platelets, in which it is stored in the alpha granules. 
Production and release of PAI-1 is increased by several stimuli. PAI-1 has been regarded as 
an acute phase reactant (e.g. after trauma and surgery) and increased PAM levels have been 
found also in chronic processes such as inflammation and cancer. Corticosteroids stimulate 
PAM release in hepatoma cells, fibroblasts and embryonic lung cells. Endotoxin, IL-1, TNF 
and possibly corticosteroids stimulate PAI-1 release of endothelial cells. 
Plasminogen Activator Inhibitor-2 (PAI-2) 
PAI-2 or placental PAI was originally identified in the human placenta, where it is 
localized in trophoblastic epithelium. It is produced by human leucocytes, monocytes, 
macrophages and histiocytic lymphoma cells. PAI-2 in normal plasma occurs only in very 
low concentrations if it all. During pregnancy, levels of PAI-2 in plasma rise to a maximum 
in the third trimester and disappear after delivery. PAI-2 reacts with tct-PA and tcu-PA, but 
it is a poor inhibitor of sct-PA. 
Plasminogen 
Plasminogen is synthesized in the liver, has a normal plasma concentration of 2μΜ, 
a biological half life of 2.2 days and is the precursor of the serine protease plasmin. 
There are five so-called lysine binding sites (LBS) in the plasminogen molecule with an 
affinity for certain lysine-containing peptides, such as e-amino caproic acid (EACA) and 
fibrin. The concentration of plasminogen that may be activated depends on the degree of 
saturation of LBS on the plasminogen molecule. Histidine-rich glycoprotein (HRG) and 
alpha-2-ал riplasmi η (α2-ΑΡ) attach to the LBS and, in this way, have an anti fibrinolytic 
effect. 
Alpha-2-ant¡plasmili (α2-ΑΡ) 
α2-ΑΡ, a senne protease inhibitor, is synthesized in the liver, has a normal plasma 
concentration ot 2μΜ, has a biological hall-lite ot Ì 1 days and is the most important 
inhibitor ot plasmin The reaction between a->-AP and plasmin proceeds in two steps The 
first step is the very tast formation of a reversible complex, involving the LBS of plasmin, 
and this is followed by a second phase of a slower irreversible intramolecular transition 
Besides inhibition of plasmin, a2 antiplasmin interferes with the adsorption of plasminogen 
to fibrin (like EACA and tranexemic acid) and undergoes cross-linking with the alpha chains 
of fibrin during clotting In this way a2 ΛΡ prevents the clot from premature lysis a7-AP 
binds free circulating plasmin very fast and protects plasma proteins and cell surface proteins 
from breakdown by plasmin 
Other plasminogen inhibitors 
Alpha-2 macroglobulm is a "second defense line" inhibitor of the fibrinolytic system 
and inactivates plasmin, kallikrein, t PA and tcu-PA relatively slowly 
HRG interacts with plasminogen via the LBS The plasminogen-HRG complex does 
not attach to fibrin In this way HRG reduces available plasminogen 
Fibrinogen, Fibrin, Fibrm(ogen) Degradation Products 
Fibrinogen, a soluble glycoprotein, is composed ol six chains, two Ac* chains, two 
Ββ chains and two 77 chains These six chains are held together by disulphide bridges 
Thrombin is formed following activation ot the coagulation system and cleaves small 
peptides (fibnnopeptides A and B) from the Ac* and Ββ chains The resulting fibrin 
monomers interact with each other and polymerize forming a fibrin clot Factor XIII, 
activated by thrombin, catalyses a process of cross-linking with the formation of 
intermolecular isopeptide bonds of adjacent fibrin monomers 
Digestion of fibrin by plasmin causes cleavage of the Ac* chains resulting m formation 
of fragments X Asymmetric cleavage of fragments X results in one fragment Y and one 
fragment D Cleavage of the Y fragment yields another D fragment and one fragment E The 
fragments X, Y, D and E constitute the fibrin degradation products (TbDP) Digestion of 
fibrinogen results in the same way in fibrinogen degradation products (FgDP) Total 
degradation products (TDP) include both FbDP and FgDP 
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Fibrinolysis 
The mechanisms of coagulation and fibrinolysis can vary in different places and 
situations (intravascular and extravascular, arterial and venous, disseminated intravascular 
coagulation). Coagulation in extravascular compartments (and in vitro) results in the 
formation of fibrin, followed by clot retraction (increase of fibrin concentration). This is 
followed by stabilization (cross-linking of fibrin, binding of a2-AP, local increase of PAI-1 
and plasmin inhibitors). 
Before retraction and stabilization, the fibrin clot is susceptible to lysis and the extent 
of clot formation is dependent on the amount of t-PA present. The process of contraction and 
stabilization is followed by destabilization of the fibrin deposit. Destabilization is mainly 
caused by inactivation of inhibitors. Within the fibrin deposit the inactivation of PAI-1 is 
relatively rapid (half life IV2 hours), of α
Γ
ΑΡ (half life 8 days) rather slow. During 
destabilization cellular invasion of the fibrin clot occurs. Polymorphonuclear leucocytes 
(PMNs) invade the fibrin clot several hours after fibrin formation. PMNs disrupt the 
structure of the fibrin deposit and facilitate in this way the exchange between deposit and 
environment. PMNs may assist in fibrinolysis during the initial phase of lysis by elastase, 
which inactivates a2-AP. After the PMNs, macrophages appear. When activated, they 
produce scu-PA and PAI-2. During destabilization inhibitors are inactivated and dormant 
activators are able to become effective. In this way it is possible that t-PA, which is present 
during initial fibrin formation, survives the lag phase and becomes active later. In vitro 
endogenous t-PA can lyse clots even after days. The initial lytic phase with partial 
degradation of fibrin is followed by the rapid lytic phase with further formation of partially 
degraded fibrin and increased binding of plasminogen and t-PA and scu-PA (91). After 
fibrinolysis the stimulatory effect of fibrin on t-PA is lost, tct-PA and tcu-PA are inhibited 
by PAI-1 and PAI-2 and plasmin is no longer protected from inactivation by a2-AP (the 
damping phase). 
2.7 Fibrinolytic assays 
A brief discussion follows about some fibrinolytic assays and the interpretation of 
these as far as they are relevant to the subject of this thesis (92,93). 
The fibrin plate method is a well-known screening method for fibrinolysis. Its 
principle is simple. To examine the PAA of a sample, some drops of this sample are placed 
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on a thin layer of plasminogen-rich fibrin. The fibrin plate is incubated at 37°C for 17 to 20 
hours and the sizes of the resulting lysis zones are measured. Comparison with lysis zones 
of dilutions of standard preparations gives an estimate of the activity of PAA in the sample. 
Heated plates, in which plasminogen has been destroyed, enable us to discriminate between 
PAA and other proteolytic activity (for example plasmin) in the sample. The fibrin plate 
method measures overall fibrinolytic activity. The results of this method are dependent on 
both activators and inhibitors of fibrinolysis and do not discriminate between them. 
Clot lysis methods are used to measure PAA in blood. The methods are based on lysis 
of blood clots, diluted blood clots and euglobulin clots. With these methods the time required 
for complete lysis of clots is determined. With the use of standard solutions, lysis times of 
the examined sample can be converted in PAA. The results of the whole or diluted clot lysis 
time methods depend, like the fibrin plate methods, on both activators and inhibitors of 
fibrinolysis. The euglobulin clot lysis time (ECLT) is a more specific procedure, in which 
a euglobulin fraction is precipitated by dilution and acidification. The euglobulin fractions 
contain plasminogen activators and much of the plasminogen and fibrinogen and reduced 
amounts of inhibitors. Prolongation of ECLT and other clot lysis methods could be the result 
of a decrease of plasminogen activators, an increase of plasminogen inhibitors or activator-
inhibitor complexes or a plasminogen or fibrinogen defect. 
Assays of the different components of the fibrinolytic system give us a better 
understanding of fibrinolysis and of the processes in which fibrinolysis is involved. These 
assays are based on enzymatic activity, immunological properties or a combination of these 
two in the form of a bioimmunoassay. Using these methods, both antigenic and activity levels 
of t-PA, u-ΡΑ and PAI have been tested. The enzyme immunoassay, that was used to 
examine tissue-type plasminogen activator antigen (t-PA-Ag), measures both free t-PA and 
t-PA complexed with inhibitor. For example, a reduced level of both t-PA activity and 
antigen suggests low release, while low activity with a normal antigen level indicates an 
increase in t-PA - PAI complex. Plasminogen activator inhibitor antigen (PAI-Ag) was 
assayed by an enzyme immunoassay. This test measures both free PAI-1 and PAI-1 
complexed to activators. 
The u-PA-Ag assay measures u-PA-Ag irrespective of its molecular form, scu-PA and 
tcu-PA (94). The plasmin-activatable u-ΡΑ activity, scu-PA, and active tcu-PA activity are 
measured by a biological immunoassay (95). 
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2.8 SUMMARY 
Intraperitoneal adhesions are common in men and women. The prevalence of 
adhesions, based on data collected from autopsies ranges between 33 and 45%. The 
prevalence of adhesions in men and women with a history of laparotomy is significantly 
higher than in individuels without laparotomies. 
Nowadays, adhesions are the most common cause of intestinal obstruction. Most 
patients with intestinal obstruction caused by adhesions have a history of laparotomy. 
The connection between the existence of adhesions and pain is obscure. The relation 
between lysis of adhesions and relief of pain is not evident. Most existing studies on 
adhesions and pain are referring to purely somatic aspects and do not take into consideration 
integrated pain models. 
Pelvic adhesions may cause infertility in women by impeding sperm, ovum and 
embryo transport. However, the correlation between the extent of periadnexal adhesions and 
pregnancy rates is not evident. Infertility in the presence of adhesions is not only the result 
of the adhesions itself but is also determined by the underlying disease which caused adhesion 
formation. 
Intraperitoneal adhesions in women are caused by abdominal surgery, infection and 
endometriosis. The classic concept of the pathogenesis of adhesions is that peritoneal injury 
may cause a reduction of intraperitoneal fibrinolysis. When the intraperitoneal fibrinolysis 
is inadequate, lysis of early fibrinous adhesions is prevented resulting in the formation of 
permanent fibrous adhesions. The process of fibrinolysis is determined by the t-PA and u-PA 
pathway and controlled by activators and inhibitors of the fibrinolytic system. 
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INTRODUCTION 
The prevention of peritoneal adhesions has been an area of intense interest to the 
abdominal surgeon for almost a century. The most common causes of adhesions in women 
are abdominal surgery, infection and endometriosis. Pelvic adhesion formation represents a 
considerable problem in causing infertility (1). Peritoneal adhesions also greatly impair 
potential improvement in fertility, which may be achieved by such surgical techniques as 
fallopian tube repair. There is a clear relationship between adhesions and intestinal 
obstruction (2), the relationship between adhesions and pain is less obvious (3,4). 
We still do not know all the etiological aspects of adhesion formation. Peritoneal 
injury causes loss of mesothelium and an inflammatory response with outpouring of a 
serofibrinous exudate. This exudate coagulates within a few hours (5). When the fibrinolytic 
capacity of the peritoneum is adequate, fibrin is lysed and mesothelial repair occurs. When 
intraperitoneal fibrinolysis is inadequate, the fibrin may persist, resulting in permanent 
fibrous adhesions brought about by organization of the fibrin clot through proliferation of 
fibroblasts and deposition of collagen (6,7,8). The etiology of adhesions in endometriosis 
remains unclear, the mechanisms by which infection induces adhesions has yet to be fully 
established (9,10). 
In 1942 Boys (11) described "five fundamental attacks" directed towards the 
prevention of adhesions, and these remain the basis of current research into adhesion 
prevention. These "attacks" are: 
1. to limit or prevent initial peritoneal injury, 
2. to prevent the coagulation of the serous exudate, 
3. to remove or dissolve the deposited fibrin, 
4. to keep apart the fib ri η-coated peritoneal surfaces until mesothelial i zati on has 
occurred and 
5. to inhibit the fibroblastic proliferation once established. 
Boys concluded from his review of the literature that only one prophylaxis has been 
established against peritoneal adhesions, namely, the minimization during surgery of all 
forms of peritoneal damage. The measures he cited for facilitating adhesion prevention by 
limiting peritoneal injury are the basis of microsurgical techniques applied today. These 
measures include gentle tissue handling and accurate and prompt haemostasis. Later, the 
"fifth attack" of inhibition of the fibroblastic proliferation has been extended to the inhibition 
of the inflammatory reaction in general (12). Table 1 (page 56) summarizes a number of 
currently used agents employed in the prevention of adhesion formation. 
A large number of therapeutic methods have been applied in an effort to reduce 
adhesion formation. Unfortunately, most studies in which experimental methods are used to 
induce adhesions show a lack of uniformity, making it very difficult to evaluate the efficacy 
of treatment programmes. Various species are used, there are different methods of inducing 
adhesions, the dosage and the route of administering of the therapeutic agent or agents may 
vary, and effectiveness is evaluated in different ways. Clinical studies are often not 
randomized or double blinded, or do not include a second look operation. 
This review of the literature of adhesion prevention will be limited to those modalities 
recently or currently being utilized clinically or experimentally. 
REDUCTION OF THE INFLAMMATORY REACTION 
Prevention of fibroblastic proliferation has been attempted with corticosteroids, non-
steroidal-anti-inflammatory-drugs (NSAIDs), antihistamines, progesterone, colchicine and 
calcium-channel blockers. (Table 1). 
Corticosteroids inhibit both the early phenomena of the inflammatory process (e.g. 
fibrin deposition) and later manifestations (proliferation of capillaries and fibroblasts, 
deposition of collagen) (13). 
Most animal studies have established a reduction of adhesion formation with 
corticosteroids after peritoneal injury (14-23). The majority of these studies are not 
randomized and do not show conclusive results. Two studies in monkeys, one of them 
randomized, have failed to show corticosteroids to be effective (24,25). Only few data are 
available on the efficacy of these drugs in adhesion prevention in man. The only report of 
a prospective randomized study that has appeared so far fails to show any beneficial effects 
of the combined administration of intraperitoneal and systemic corticosteroids in preventing 
adhesion formation (26). 
One of the most common side effects of corticosteroids when applied to adhesion 
prevention is delayed wound healing because of the immunosuppressive action of 
corticosteroids (27). In view of this immunosuppression, most studies report that antibiotic 
prophylaxis is given concomitantly and (in older studies) non-absorbable sutures have been 
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used for wound closure. Other commonly reported side effects are bone and muscle pain and 
psychiatric disturbance after completion of the steroid treatment (28). 
More recently, attention has turned to the NSAIDs as good alternatives to 
corticosteroids for the reduction of the inflammatory response. Ibuprofen is the most studied 
NSAID in relation to adhesion prevention (29-34). Propionic acid derivatives, like Ibuprofen, 
are anti-inflammatory agents and have inhibitory effects on the migration and other functions 
of leucocytes (35). The results of studies using Ibuprofen are contradictory and the efficacy 
of Ibuprofen has not been proven. 
Histamine antagonists, such as promethazine, are generally used in combination with 
corticosteroids. Promethazine, an H, antagonist, strongly blocks the action of histamine that 
results in increased capillary permeability (36). The effectiveness of promethazine in 
preventing adhesion formation alone has not been examined. 
Progesterone has been reported to have anti-inflammatory and immunosuppressive 
properties (37). Maurer and Bonventura evaluated the effect of progesterone on operative 
adhesion prevention in guinea pigs (38). Both intramuscular and intraperitoneal use reduced 
adhesion formation. However, these results are not supported by later studies. Progesterone 
has even been reported to promote post-operative adhesion formation (39,40). 
Colchicine is an anti-inflammatory agent and it is largely effective against gouty 
arthritis. Colchicine inhibits the release of histamine-containing granules from mast cells, and 
has antimitotic properties (35). In a randomized study Granat et al. administered colchicine 
intramuscularly to rats and noticed that adhesion formation was significantly reduced as 
compared with both an untreated group and a group treated with dexamethason (41). No data 
are available on studies in man. 
In the last few years, calcium-channel blockers have been employed in adhesion 
prevention. The mechanisms by which calcium- channel blockers influence adhesion 
formation and peritoneal healing is uncertain, they may have an anti-inflammatory effect. 
Steinleitner et al. reported that calcium entry blockers prevented adhesion formation in two 
randomized animal studies (42,43). Also here no data are available on performance in the 
human body. 
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INHIBITION OF COAGULATION 
Anticoagulants have been used in an effort to prevent fibrin deposition. Heparin can 
be administered systemically and intraperitoneally. Older studies have shown heparin to be 
effective in preventing adhesion formation (11). However, the serious risk of haemorrhage, 
documented in early laboratory and clinical studies put a premature end to further research. 
Recently, Jansen has shown in a clinical prospective, randomized, controlled study that an 
intraperitoneal dose of 5000 IE exerted no important action in reducing development of 
peritoneal adhesions (44). 
PROMOTION OF FIBRINOLYSIS 
After peritoneal injury, plasminogen activator activity (PAA) of peritoneum or 
peritoneal fluid is decreased or inadequate. This holds true for both laparotomy and 
peritonitis (7,8,10,45). Therefore, the therapeutic use of plasminogen activators to prevent 
adhesion formation seems reasonable. 
This was attempted initially with the plasminogen activators fibrinolysin, streptokinase 
and urokinase, with differing results (46-51). 
Tissue-type plasminogen activator (t-PA) has several advantages as compared with the 
plasminogen activators used previously. It is not antigenic and it has few general side effects, 
if any, in blood coagulation. Until now only animal studies have been published. Both in rats 
(52) and rabbits (53,54) t-PA appeared to be an effective and safe inhibitor of adhesion 
formation after intra-abdominal administration. There is a need for clinical studies to be 
carried out. 
SEPARATION OF SURFACES 
It is possible to keep injured, fibrin-covered, peritoneal surfaces apart by introducing 
a solution into the abdominal cavity and keeping it there long enough to permit mesothelial 
repair and to prevent adhesions. Two types of solution can be used: either a large quantity 
of an isotonic solution or a smaller amount of a hypertonic solution which has the potential 
to form enough transudate for the desired purpose. 
Already in 1902, Vogel (55) used hypertonic saline or glucose to create a large 
amount of fluid between bowel surfaces. After this attempt a large number of different 
substances like olive oil, liquid paraffin, fish bladder and amniotic fluid, have since been 
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brought into the abdominal cavity. Nevertheless, most of these increased adhesion formation 
instead of preventing them (56). 
Nowadays, dextran is the most commonly used substance employed to separate 
injured mesothelial surfaces. Dextran, a hypertonic solution, is slowly resorbed from the 
peritoneal cavity and produces mechanical separation of adjacent surfaces (hydroflotation 
effect). 
The precise mechanism by which dextrans impede adhesion formation is not yet fully 
understood. As well as causing ascites, the structure of fibrin is altered when formed in the 
presence of low concentrations of dextran 70, making it more susceptible to degradation (57). 
In vitro studies also show a higher concentration of plasminogen activator on the peritoneal 
surfaces in the presence of dextran 70. Dextran could prevent the floating away of 
plasminogen activator into the free abdominal cavity, concentrating fibrinolysis on the most 
important places (58). However, hydroflotation seems to be the predominant mechanism. 
Low-molecular-weight dextran (dextran 40) was first evaluated as an agent for 
adhesion prophylaxis in 1964 (59). The numerous reports that followed were initially 
enthusiastic (60,61), although others did not find any difference in the formation of adhesions 
between treated groups and controls (62,63). Later, high-molecular-weight dextrans (dextran 
70) have received greater interest. Only a minority of the experiments in animals showed 
32% dextran 70 to be beneficial (63-81). Thus far, four randomized clinical trials have 
appeared (26,82-84). Both the Adhesion Study Group (82) and Larsson et al. (83) performed 
a prospective randomized double blind study comparing 32% dextran 70 with saline. The 
results were contradictory. The Adhesion Study Group found 32% dextran 70 to reduce 
postoperative adhesions effectively, Larsson et al. were unable to demonstrate differences in 
reduction of adhesions in the dextran- and saline group (82,83). In a prospective randomized 
study Rosen burg et al. compared 32% dextran 70 with Ringer's lactate and found 32% 
dextran 70 to be more effective (84). In a similar study Jansen noticed no reduction of 
adhesions either with dextran, or with Ringer's lactate (26). 
The following side-effects of the intraperitoneal use of dextran have been reported: 
anaphylactic reactions, impaired haemostasis, fluid imbalance due to the intraperitoneal 
osmotic load, increased body weight, vulvar edema, transient liver function disturbances and 
infections (85,86). Post-operatively, dextran 70 may develop asymptomatic pleural effusion 
(87). There is one case-report of the development of bilateral pulmonary edema and 
coagulopathy after using 32% dextran 70 as a distention medium for hysteroscopy (88). 
Anaphylactic type reactions are mentioned after intravenous and intra-abdominal use and after 
use at hysteroscopy with an incidence of 1:10.000 (89,90). People with a history of asthma 
and atopic constitution are reported to be at particular risk. 
Bacteria can be cultured with ease in dextran (91), although Elkins et al. reported the 
opposite (92). When applying dextran concomitantly antibiotic prophylaxis is advised; 
however, there are no reports of an increased risk of infection. 
In a randomized, blind study in the rat, hyaluronic acid appeared to reduce 
intraperitoneal adhesion formation (93). Hyaluronic acid, a connective tissue polysaccharide, 
forms a viscous solution that appears to coat serosal surfaces. Further studies are necessary 
to ascertain whether hyaluronic acid should be used as an agent for adhesion prevention. 
Another way to keep surfaces apart from one another is to separate them by natural 
or artificial barriers. Natural grafts of materials such as amnion, omentum and peritoneum 
usually promote adhesion formation instead of preventing it (56,94). In a recent study, Young 
et al. have shown that specially-prepared amniotic membranes reduced post-operative 
adhesion formation in a rabbit model (95). Synthetic barriers can be non-absorbable, like 
nibber or teflon. When used, however, a second operation is necessary to remove the grafts. 
More recently, absorbable barriers have been used consisting of oxidized and regenerated 
cellulose (SurgigelR), Polaxamer 407 (a temperature-dependent polymer) and meshes of Gore-
TexR (expanded polytetrafluoroethylene) and InterceedR (TC7, oxidized regenerated 
cellulose). Animal studies have shown that SurgigelR, originally designed as a haemostatic 
agent, increased adhesion formation in some studies and prevented it in others (96-100). 
Polaxamer 407 is a polymer that exists as a liquid at room temperature and changes 
to a solid gel at body temperature. In animal studies, Polaxamer was seen to reduce both 
adhesion formation and reformation (101,102). Gore-TexR was an effective barrier for 
adhesion prevention in most animal studies (103-106). InterceedR (TC7) is an oxidized 
regenerated cellulose, chemically identical to SurgigelR, but woven differently. It has been 
developed as a surgical adjuvant to prevent adhesions. Data on the efficacy of InterceedR 
vary. In an rabbit study, Linsky et al. demonstrated that TC7 was effective in reducing 
adhesion formation (107). Diamond et al. have shown in rabbits that when heparin was 
applied to InterceedR a reduction of adhesion formation occurred (108). Other animal studies 
have failed to show a beneficial effect of InterceedR on the prevention of adhesions (105, 
109-111). Studies in men are limited. There is only one prospective, randomized, 
multicentre, clinical study that has evaluated the efficacy of InterceedR in reducing adhesions 
in man. This study reported TC7 to be effective in the prevention of post-surgical pelvic 
adhesions (112). 
SURGICAL TECHNIQUE 
The only issue, which all investigators seem to agree on, concerning adhesion 
prevention, is that a meticulous surgical technique can limit the extent of post-operative 
adhesions. As early as 1932, Babcock emphasized the importance of gentle tissue handling 
(113). References to meticulous haemostasis, delicate instrumentation and careful tissue 
handling can be found in the literature from the first decades of this century. 
Microsurgical techniques emphasize not only magnification with magnifying loupes 
or an operating microscope, but also proper surgical exposure, gentle tissue handling, 
prevention of tissue drying with frequent irrigation, careful haemostasis, the use of fine-
tipped instruments such as microbipolar forceps or unipolar microelectrodes, and minimising 
tension in suture lines. Use of fine suture and small needles decreases the likelihood of 
rendering large amounts of tissue ischemia (114). 
Bateman et al. reviewed the results of several studies comparing the results of 
microsurgical versus macrosurgical salpingostomies. Microsurgical series had more 
consistent, and slightly higher, term pregnancy rates, but also higher ectopic pregnancy rates 
than conventional surgery. Few studies were comparable in terms of factors such as length 
of follow-up after surgery, severity of tubal disease, anti-adhesion adjuvants used, 
hydrotubation and expression of data (115). The incidence of post-operative adhesions 
following microsurgical wedge resection was low compared with a macrosurgical procedure 
(116). Tubal reconstruction for reversal of sterilization showed better results regarding tubal 
patency and pregnancy rates following microsurgery (117,118). The benefit of microsurgery 
in lysis of adhesions is not clear (119). 
Babcock et al. demonstrated as early in 1932 that surgical reperitonealization nearly 
always created severe adhesions (113). Peritoneal defects should therefore be left as raw 
surfaces rather than pulled together under tension (94,120). 
It seemed that blood alone will not induce adhesions. However, blood combined with 
tissue ischemia, foreign bodies or serosal drying will invariably induce adhesions (121). 
Irrigation of the operative field with saline is said to cause tissue edema (114). Ringer's 
lactate is perhaps a better alternative because it contains more appropriate electrolytes. In a 
randomized study in the rat, intraperitoneal installation of Ringer's lactate was effective in 
the prevention of adhesion formation (105). The mechanism by which Ringer's lactate may 
prevent adhesions is unknown. Theoretically, the use of heparin-containing wetting solutions 
should reduce the intra-operative deposition of fibrin. In 1988, Jansen reported this not to 
be the case in a randomized clinical study (44). 
Agreement exists that every effort should be made to reduce foreign-body 
contaminants, which may trigger or augment an intra-abdominal, inflammatory response. In 
this respect, glove dusting powder is the main offender (122). Good cleaning of cornstarch 
powder gloves is therefore very important. Quick washing procedures can leave some 
cornstarch on the gloves which pastes together. Procedures for washing or rinsing include 
sterile water, saline, detergent or antiseptic solutions. Another procedure is to wipe the 
gloves with sterile dry towels or with wet sponges. Several studies have demonstrated that 
even after repeated washing, loosely aggregated clumps of starch are left on the outside of 
the gloves. It is probably better to use non-powdered gloves (123,124). 
It is said that suture materials should be atraumatic, thin and inert. However, there 
are no differences in microscopical tissue reaction to various absorbable and non-absorbable 
suture materials (125,126). Studies comparing different kinds of suture material (chromic, 
nylon, polyglactin [VicrylR], polyglycolic acid [DexonR]) revealed no significant differences 
in adhesion formation (33,110,127,128). 
There is still only minimal information on the effectiveness of operative laparoscopy 
with respect to adhesion prevention. The Operative Laparoscopy Study Group showed in a 
multicentre clinical trial that after laparoscopical adhesiolysis the incidence of post-operative 
adhesion reformation was no less than had previously been reported after laparotomy 
(129,130). However, de novo adhesion formation occurred less. On the other hand, 
laparoscopic excision of endometriosis may be followed by de novo formation of pelvic 
adhesions (131). A study by Lundorff et al. demonstrated that laparoscopic management of 
tubal pregnancy caused fewer adhesions post-operatively than laparotomies on both the 
treated and contralateral adnexa. It has yet to be ascertained whether this reduction of 
adhesions will increase subsequent fertility (132). 
Lately, there has been considerable interest in gynaecologie laser surgery. The 
number of comparative clinical studies that have evaluated the effectiveness of laser surgery 
on adhesion formation or reformation is low. No significant differences have yet been 
identified compared with conventional micro-surgery (133,134). 
The usefulness of second-look laparoscopy in assessing the results of infertility 
surgery and in lysing post-operative adhesions has been investigated by many authors since 
this technique was first used by Swolin in 1967 (135). It can be carried out at intervals from 
8 days to 8 weeks or even longer after operation (136,137). Conversion from fibrinous 
attachments to permanent fibrous adhesions starts during the third or fourth day after surgery. 
Laparoscopic adhesiolysis of the early filmy adhesions is less difficult, less traumatic and 
involving less bloodshed (138). Trimbos et al. concluded that more than half of the adhesions 
removed at early second-look laparoscopy had not recurred after one year (136). Jansen 
confirmed these findings (139). The studies of Trimbos et al. and of Jansen were not 
randomized. A third look procedure was performed only in patients in whom pregnancy had 
failed to occur or for other reasons (ectopic pregnancy, GIFT laparoscopy). The effect of 
second look laparoscopy after infertility surgery on subsequent pregnancy rates has still to 
be determined. 
SUMMARY AND CONCLUSION 
Intraperitoneal adhesions in women may be caused by abdominal surgery, 
inflammation and endometriosis. Fibrin is deposited in areas of mesothelial injury. When 
intraperitoneal fibrinolysis is inadequate the fibrinous clot is organized by fibroblastic 
proliferation and deposition of collagen, resulting in permanent fibrous adhesions. Adhesions 
are the most common cause of bowel obstruction and may cause infertility and pain. 
Research into adhesion prevention has been focused on the limitation of the initial 
peritoneal injury (microsurgery, laparoscopic surgery), inhibition of the inflammatory 
response, prevention of coagulation of fibrinogen, removal of the deposited fibrin, and 
mechanical separation of the injured, fibrin-covered mesothelial surfaces. 
Although the importance of meticulous surgical techniques to minimize peritoneal 
trauma in order to prevent adhesions has been established in several studies, the benefit of 
microsurgical techniques for future fertility is not clear in all studies and in all indications. 
It does not appear that laparoscopic adhesiolysis results in a greater reduction of 
postoperative adhesion reformation compared with the reduction of adhesions after 
adhesiolysis at laparotomy. The outcome of studies on the effectiveness of laparoscopical 
adhesiolysis at second look laparoscopy is promising. The benefit of adhesiolysis at (second 
look) laparoscopy and of laparoscopic surgery in general with regard to the ultimate aims of 
surgery (e.g. treatment of infertility, relief of pain) has to be ascertained. 
Agents employed to reduce the inflammatory reaction (e.g. corticosteroids and 
NSAIDs) and to inhibit coagulation (heparin) have not proved to be useful for adhesion 
prevention. 
In animal studies the intraperitoneal administration of t-PA seems to be effective in 
preventing adhesions. These results must be confirmed in clinical studies. 
Regarding dextrans, it can be concluded that the results of experimental research in 
animals and of clinical trials do not justify the use of dextrans in clinical practice. The 
outcome of animal studies regarding the effect of absorbable barriers on adhesion prevention 
is variable. Absorbable barriers have been examined in only one human study. The 
usefulness of these barriers for clinical practice has, therefore, still to be determined. 
In spite of many decades of research on the pathogenesis and prevention of 
adhesions, we still do not know all the etiological aspects of adhesion formation and it is still 
not possible to prevent them adequately. More research is needed, first to learn and 
understand the mechanisms of adhesion (re)formation and then, with this knowledge, to 
develop better methods for adhesion prevention. 
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Table 1. Agents employed for adhesion prevention, discussed in chapter 3. 
Reduction of inflammatory reaction: 
Corticosteroids 
Non-steroidal-anti-inflammatory drugs: 
Ibuprofen, i ndomethacin. 
Histamin antagonists: promethazine 
Progesterone 
Colchicine 
Calcium channel blockers 
Inhibit coagulation: 
Heparin 
Oral anticoagulants 
Promotion of fibrinolysis: 
Fibrinolysin 
Streptokinase 
Urokinase 
t-PA 
Separation of surfaces: 
Natural membranes: amniotic membrane, 
free graft of omentum or peri-
toneum 
Synthetic barriers: rubber, teflon, 
silver foil, Interceed (TC7), polyetra-
fluoroethylene (Gore-Tex), Polaxamer 407. 
Instillation of fluid: saline, dextran, 
hyaluronic acid. 
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SUMMARY 
The purpose of this study was to investigate differences in fibrinolytic activity in 
peritoneal fluid and plasma of women in the first and second part of the menstrual cycle. 
Given the classic concept of decreased fibrinolytic activity as a cause of adhesion formation, 
then if such differences are found, the stage of women's menstrual cycle should be taken into 
consideration when scheduling a laparotomy. 
We measured fibrinolytic parameters in peritoneal fluid and plasma in eight women 
in the pre-ovulatory period and in eleven women in the post-ovulatory period of the 
menstrual cycle. 
There were no differences in t-PA-Ag, t-PA-Act, u-PA-Ag and scu-PA concentrations 
in peritoneal fluid between the pre- and post-ovulatory group. Nevertheless, PAI-l-Ag in 
peritoneal fluid was three-fold higher in the post-ovulatory phase (p<0.02). In peritoneal 
fluid the concentrations of both TDP and FbDP were three-fold higher at the same phase 
(p<0,05). 
Plasma u-PA-Ag and scu-PA concentrations were significantly lower (30%, p<0.05) 
in the post-ovulatory phase and also lower than plasma u-PA-Ag and scu-PA (measured with 
the same assay) in a group of 50 healthy individuals. No differences in t-PA and PAI 
concentration were found. 
In conclusion, the intraperitoneal fibrinolytic capacity might be impaired in the second 
part of the menstrual cycle, regarding the elevated levels of PAI-l-Ag, leading to an 
increased risk for post-ovulatory adhesion formation. The low plasma u-PA-Ag and scu-PA 
levels post-ovulatory may have clinical relevance. 
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INTRODUCTION 
Pelvic adhesion formation is a major cause of infertility in women (1). Adhesions are 
the most common cause of bowel obstruction (2). Intraperitoneal adhesions may be caused 
by laparotomy, inflammation and endometriosis. Fibrin is deposited in areas of mesothelial 
injury. When intraperitoneal fibrinolysis is inadequate the fibrinous clot is organized by 
fibroblastic proliferation and deposition of collagen, resulting in permanent fibrous adhesions 
(3,4,5). 
Intra-abdominal processes may influence intraperitoneal fibrinolysis. Concerning 
intraperitoneal inflammation, it was shown that the peritoneal plasminogen activator activity 
(PAA) was reduced (6,7). In a previous report we concluded, that during pelvic 
inflammatory disease (PID) PAA in the peritoneal fluid, although enhanced, could not meet 
the demand to neutralize stimulated coagulation (8). 
Plasminogen activators are involved in the process of ovulation (9,10,11). Some 
studies have shown that tissue-type plasminogen activator (t-PA), urokinase-type plasminogen 
activator (u-ΡΑ) and plasminogen activator inhibitor (PAM) are secreted by ovarian 
granulosa cells (12). The production and secretion of t-PA and u-ΡΑ by ovarian granulosa 
and theca-interstitial cells are regulated by the gonadotropins FSH (Follicle Stimulating 
Hormone) and LH (Luteinising Hormone) and by GnRH (Gonadotropiη-Releasing Hormone) 
(13,14,15). Because the concentrations of ovarian steroids, gonadotropins and prostaglandins 
in peritonea] fluid are influenced by cyclic ovarian activity (16,17), it is possible that there 
are differences in concentration of the components of fibrinolysis of peritoneal fluid 
throughout the menstrual cycle. 
The fibrinolytic components of plasma are influenced by a variety of circumstances 
like: physical exercise, mental stress, surgery, sepsis, and cancer. A number of substances, 
such as vasopressin and cytokines, determine the levels of activators and inhibitors of 
fibrinolysis in plasma. 
Some studies have considered the components of fibrinolysis in peritoneal fluid of 
women without intraperitoneal pathology (18,19,20,21). It was inferred that the fibrinolytic 
activity of the peritoneal fluid may depend on the stage of the menstrual cycle (19). If this 
holds true, the stage of the menstrual cycle should be considered in scheduling laparotomies 
in women. Therefore, we have studied the influence of the menstrual cycle on activators and 
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inhibitors of fibrinolysis in the peritoneal fluid comparing the pre-ovulatory and the post-
ovulatory mid-luteal periods. We also compared the fibrinolytic parameters of plasma. 
MATERIAL AND METHODS 
Twenty eight patients underwent laparoscopy for sterilisation. The operation was 
performed in the preovulatory period in eight patients (day 9 - day 12 of the menstrual cycle) 
and in the postovulatory mid-luteal period in eleven patients (day 19 - day 22 of the 
menstrual cycle). The average age of the women in the pre-ovulatory group was 33 years 
(29-36 years), and of the women in the post-ovulatory group 34 years (29-40 years). 
The selection criteria were as follows: 
no evidence of any abdominal pathology, based on their pre- operative history and 
physical examination, 
no history of abdominal or vaginal operations, except uncomplicated appendectomy, 
regular menstrual cycle (23-32 days), 
delivery of at least one live-born child, 
no use of any medication, including oral contraceptives, 
no IUD, 
not lactating, 
during laparoscopy no evidence of any intraperitoneal abnormality (adhesions, 
endometriosis). 
Laparoscopy was performed under general anaesthesia. Peritoneal fluid was aspirated 
from the pouch of Douglas and vesicouterine space. Two samples of peritoneal fluid were 
collected, one in 0.11 M trisodium-citrate and another sample in EDTA. The citrate tube was 
placed in melting ice and within 90 min. centrifuged. The supernatant was then stored at -
40°C. Haemoglobin concentration was measured in the peritoneal fluid collected in the 
EDTA-tube. 
During laparoscopy, 10 ml. venous blood was sampled; 1.8 ml. was collected in a 
citrate tube and handled as mentioned above, the remainder was used for determination of 
estradiol and progesterone. 
Estradiol was measured with the Coat-A-Count Estradiol RIA kit of DPC (Diagnostic 
Products Corporation, Los Angeles, USA). Progesterone was determined by the Amerlex-M 
Progesterone RIA kit (Kodak Clinical Diagnostics Ltd, Amersham, Cardiff, UK). Mean mid-
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luteal progesterone reference value of this kit is 32.08 nmol/l, with a range of 19.36-56.85 
nmol/1. 
Tissue-type plasminogen activator antigen (t-PA-Ag) was assayed by an enzyme 
immunoassay, using anti-t-PA antibodies (Immulyse™ t-PA, Biopool AB, Umeâ, Sweden). 
The test measures both free and complexed t-PA. Plasminogen activator inhibitor antigen 
(PAl-1-Ag) was assayed by an enzyme immunoassay, using anti-PAI antibodies (Tint-Elize™ 
PAI-1, cat. No 210221, Biopool AB, Umeâ, Sweden). The test measures both free PAI-1 and 
PAI-1 complexed to activators. Activity of tissue-type plasminogen activator (t-PA-Act) was 
assayed according to Verheijen et al. (22). Total urokinase type plasminogen activator 
antigen (u-PA-Ag), plasmin-activatable single-chain u-ΡΑ (scu-PA) and active two-chain u-
PA (tcu-PA) were measured using a combination of an ELISA and a biological immunoassay 
and the activities were correlated with antigen levels through calibration (23,24). The lower 
detection limit in our material was 0.1 ng/ml. Fibrin degradation products (FbDP) and 
fibrinogen degradation products (FgDP) were determined both together (TDP) and separately 
in the peritoneal fluid with an enzyme immunoassay, Fibrinostika Microelisa system 
(Organon Teknika, Boxtel, the Netherlands). 
Medians and interquartile ranges were calculated for each parameter. The Mann-
Whitney test was employed to examine the differences between the pre-ovulatory and the 
post-ovulatory group. 
The study was approved by the hospital Ethics Committee. 
RESULTS 
No ovulatory stigma was seen in eight out of ten patients during laparoscopy in the 
presumed pre-ovulatory period (day 9 - day 12). The serum estradiol level in the pre­
ovulatory period ranged between 0.10-0.97 nmol/1 (mean 0.39 nmol/1, median 0.32 nmol/1). 
In the post-ovulatory anticipated mid-luteal period in eleven out of eighteen patients the mean 
serum progesterone level was within the normal range of 23-52 nmol/1 (mean 34.1 nmol/I, 
median 30 nmol/1). The serum estradiol level in this period ranged between 0.12-0.53 nmol/1 
(mean 0.35 nmol/1, median 0.37 nmol/1). Two women of the pre-ovulatory group were 
excluded because they were actually found to be in the post-ovulatory phase, six women were 
excluded from the post-ovulatory group because serum progesterone levels were below the 
lower limit of the normal range. One woman was excluded because she had pelvic adhesions. 
Therefore, eight women in the рге-ovulatory group and eleven women in the post-ovulatory 
group remained for analysis. 
The haemoglobin concentration in peritoneal fluid in the рге-ovulatory group was 
between 0.1 - 0.6 mmol/1 and in the post-ovulatory-group between 0.1 - 1.0 mmol/1. 
Fibrinolytic parameters in peritoneal fluid and plasma are represented in tables 4.1 
and 4.2 (page 66,67). 
In the post-ovulatory group PAI-l-Ag in peritoneal fluid was three-fold higher 
(p<0.02) than in the рге-ovulatory group, while there were no significant differences in t-
PA-Ag, t-PA-Act, u-PA-Ag and scu-PA concentrations. The concentrations of TDP (p=0.05) 
and FbDP (p<0.05) were three-fold higher post-ovulatory. 
In plasma both u-PA-Ag (p<0.05) and scu-PA (p<0.05) were 30% lower in the 
post-ovulatory group. There were no significant differences between the pre- and post-
ovulatory group with regard to PAI-l-Ag, t-PA-Ag and t-PA-Act in plasma. 
DISCUSSION 
Only a few studies have examined the fibrinolytic parameters of peritoneal fluid in 
women without intra-abdominal pathology and these have noted differences (18,19,20,21). 
Padilla et al. described significant elevated plasminogen levels in peritoneal fluid after 
ovulation (21). Bouckaert et al. found that also the concentrations of a2-antiplasmin, 
anti thrombin III, fibrinogen and FbDP's were significantly higher post-ovulatory and 
speculated that fibrinolytic activity was higher during the post-ovulatory period (19). In a 
longitudinal study in rabbits, however, no pre- and post-ovulatory differences in fibrinolytic 
activity of peritoneal fluid were found (25). 
Here we report on fibrinolytic parameters in carefully selected pre- and post-
ovulatory women. Based on the selection criteria used and the age distribution in both 
groups, the examined pre- and post-ovulatory groups are comparable. We were unable to 
demonstrate differences in intraperitoneal fibrinolytic parameters between the two groups, 
except for a lower PAI-l-Ag in the рге-ovulatory group. Both TDP and FbDP were higher 
in post-ovulatory than in рге-ovulatory peritoneal fluid. This confirms the results of 
Bouckaert et al. (19). Therefore, more fibrin has been degraded after ovulation, in spite of 
the higher post-ovulatory PAI-1 levels. The paradoxically increased intraperitoneal FbDP 
concentration can be explained by a concomitant increase in the activation of the coagulation 
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cascade. The intra-peritoneal fibrinolytic capacity may be higher in the pre-ovulatory period 
due to levels of PAI-l-Ag being lower in the pre-ovulatory period. 
In plasma, there were no significant differences in concentrations of PAI-l-Ag, t-PA-
Ag or t-PA-Act in the pre- and postovulatory phases. Much to our surprise, however, we 
found significant differences in u-ΡΑ parameters. Plasma u-PA-Ag and scu-PA concentrations 
are 30% lower in the post-ovulatory group (p < 0.05). 
With the same assays we used for this study, plasma levels of 50 healthy male and 
female individuals for u-PA-Ag were 3.5 ± 1.4 ng/ml (mean ± SD), and for scu-PA 2.1 
± 0.4 nmol/1 (mean ± SD) (23,26). This means that in our pre-ovulatory group plasma u-
PA-Ag and scu-PA had the same concentrations, and that in the post-ovulatory group plasma 
u-PA-Ag and scu-PA levels were lower than in the group of 50 healthy individuals. 
Plasma u-ΡΑ levels vary in different conditions. In plasma, levels of u-ΡΑ and scu-PA 
were increased by desamino-d-arginine vasopressin (DD A VP) and physical exercise (27,28). 
It was found that plasma u-ΡΑ levels in males were significantly higher than in females (29). 
It is possible that plasma u-PA-Ag and scu-PA levels decline under the influence of 
progesterone. The influence of the menstrual cycle on the levels of u-ΡΑ in plasma is subject 
of a current longitudinal study. 
In conclusion, in the post-ovulatory phase PAI-1-Ag levels were elevated in peritoneal 
fluid. Therefore, the intraperitoneal fibrinolytic capacity might be impaired in the post-
ovulatory period resulting in an increased risk of adhesion formation in the second part of 
the menstrual cycle. In plasma u-PA-Ag and scu-PA concentrations were lower in the post-
ovulatory phase. This may have clinical relevance. When interpreting data on plasma u-PA 
levels, the stage of the menstrual cycle should be taken into consideration. 
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CHAPTER 5 
PERITONEAL FLUID AND PLASMA FIBRINOLYTIC ACTIVITY IN WOMEN 
WITH PELVIC INFLAMMATORY DISEASE 
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1. Department of Obstetrics and Gynaecology, Westeinde Hospital, The Hague. 
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3. Department of Obstetrics and Gynaecology, University Hospital, Nijmegen, The 
Netherlands 
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SUMMARY 
Previous studies have shown that the fibrinolytic activity of peritoneum is depressed 
in local inflammation. We measured fibrinolytic parameters in peritoneal fluid and in plasma 
of 10 women with pelvic inflammatory disease (PID). Nine women, in whom laparoscopy 
for sterilisation was performed, served as a control group. 
In the peritoneal fluid of women with PID, PAI-Ag, t-PA-Ag and u-PA-Ag were 
many times higher than in the control group. In contrast to the antigens which may be 
present in inert complexes, the potentially active compounds, measured as t-PA activity and 
plasmin-activatable scu-PA, were not significantly different in the two groups, and in none 
of the samples was the active enzyme tcu-PA detectable. Nevertheless, the mean peritoneal 
fluid TDP and FbDP concentrations were about twenty times higher in the PID group than 
in the control group. In plasma of PID patients, none of the parameters except u-PA-Ag 
differed from those in the control group. The difference between control and patient plasma 
u-PA-Ag was statistically significant, but too small to attach any relevance to the observation. 
Our data suggest that, in contrast to the classical concept of decreased fibrinolytic 
activity as a cause of adhesion formation, intraperitoneal fibrinolysis is enhanced in peritoneal 
inflammation through stimulation of the local production of t-PA and u-ΡΑ. Despite 
concomitant production of PAI, fibrinolysis occurs at a high rate, resulting in high levels of 
fibrin degradation products. Since this activated fibrinolysis does not meet the demand, 
therapeutic enhancement should be considered to prevent adhesions. 
INTRODUCTION 
Pelvic inflammatory disease (PID) in women is defined as inflammation of the upper 
genital tract. It is almost always due to infection ascending through the cervix, uterus and 
fallopian tubes. PID includes endometritis, salpingitis and salpingo-oophoritis, but the 
inflammation may spread to the peritoneum with peritonitis and sometimes along the 
paracolic gutter to cause the Fitzhugh-Curtis syndrome of perihepatitis (1,2). In industrialized 
countries the incidence of PID is 10 to 13 per 1000 women of reproductive age, with a peak 
incidence of 20 per 1000 in those aged between 15 and 24 years (3,4). 
Damage of the tubes resulting from PID is the commonest cause of tubal infertility 
and the impediments to the tubal passage of the ovum or embryo may lead to ectopic 
pregnancy. Tubal infertility is generally attributed to tubal obstruction by scar formation (5). 
Woodruff and Pauerstein believe that the extent of peritubal and periovarian adhesions is the 
primary determinant of tubal blockage and that intratubal pathology is of secondary 
importance (6). Tubal occlusion occurs in 13% of subjects after one infection and after two 
bouts of infections this incidence increases to 35%. After three or more infections the 
incidence rises to 75% . The ratio between ectopic and intrauterine pregnancies in the 
patient-group of Weström was one in 24 after one infection and in his control-group, one in 
147 (7). 
Peritoneal injury causes an inflammatory response of the serosal surfaces with 
outpouring of serofibrinous exudate. The integrity of the peritoneum and the fibrinolytic 
capacity determine whether the resulting fibrinous adhesions are lysed or become organized 
with proliferation of fibroblasts and formation of collagen resulting in permanent adhesions 
(8,9,10). Hau et al. have demonstrated in a dog model, that injury to the peritoneum caused 
by bacterial peritonitis greatly decreased fibrinolytic activity of the peritoneum (11). 
If adhesions are formed after PID as a sequela of decreased peritoneal fibrinolytic 
activity, efforts to artificially increase fibrinolysis activity may be warranted. For this 
purpose, detailed knowledge of the fibrinolytic system in PID is needed, not only of the 
peritoneum itself, but also of the peritoneal fluid. We compared activators and inhibitors of 
fibrinolysis in peritoneal fluid and plasma of women with PID with those of a control group. 
MATERIAL AND METHODS 
Ten patients underwent laparoscopy after a provisional diagnosis of acute pelvic 
inflammatory disease (PID). The selection criteria for the PID patients were as follows: 
no other illnesses than the suspected PID, 
no history of abdominal or vaginal operations, except uncomplicated appendectomy, 
regular menstrual cycle (between 23-32 days), 
no use of any medication, including oral contraceptives, 
no IUD , 
not lactating. 
Before laparoscopy, specimens for bacteriological cultures were obtained from the cervix, 
vagina and urethral orifice. For detection of Chlamydia trachomatis an immunofluorescent 
monoclonal antibody test was performed. Erythrocyte sedimentation rate and leucocytes were 
measured preoperative!y. 
Laparoscopy was performed under general anaesthesia within 24 hours of admission 
and before antibiotic treatment was started. The minimum criteria for the visual diagnosis of 
acute PID were: hyperaemia of the tubal surface, edema of the tubal wall and exudate on the 
tubal surface and from the fimbriated ends when patent (12,13). The severity of PID was 
defined, as mentioned by Weström and Hager et al., mild: erythema, edema, no spontaneous 
purulent exudate, tubes freely movable; moderate: erythema and edema more marked, gross 
purulent material evident, tubes may not be freely movable and patency of abdominal ostia 
uncertain; severe: pyosalpinx or inflammatory complex, abscess formation (7,14). 
Nine patients who underwent laparoscopy for sterilisation served as a control group. 
The selection criteria were as mentioned for the PID group; in addition they should have no 
evidence of any abdominal pathology, based on their preoperative history and physical 
examination. A further criterion was that the women should have delivered at least one live-
borne child. 
The mean age of the patients in the PID-group was 23 years (18-36 years), and of the 
women in the control-group 34 years (29-40 years). The difference is explained by our policy 
to perform sterilisation almost exclusively in women aged 30 years or older (15), whereas 
the peak incidence of PID in industrialized countries is observed in women aged 15-24 years 
(3,4). However, we are confident that the women, in whom laparoscopy for sterilisation was 
performed, can serve as a control group since Meade et al. showed only a small age-
dependent increase of fibrinolytic activity in 707 women aged 18-59 years until the age of 
about 39 years which was followed by a decline (16). Kirchheimer & Binder (17) found 
equal mean plasma urokinase plasminogen activator antigen (u-PA-Ag) levels in the age-
groups 21-30 and 31-40. 
Peritoneal fluid was aspirated from the pouch of Douglas and vesicouterine space. 
Two samples of peritoneal fluid were collected, one in 0.11 m trisodium-citrate and another 
sample in EDTA. The citrate-tube was placed in melting ice and within 90 minutes 
centrifuged at 4° C, the supernatant was stored at -40° C. Haemoglobin concentration was 
measured in the peritoneal fluid collected in the EDTA-tube. 
During laparoscopy, venous blood was collected in a citrate tube and handled as 
mentioned before. 
Tissue-type plasminogen activator antigen (t-PA-Ag) was assayed by an enzyme 
immunoassay, using anti-t-PA antibodies (Immulyse™ t-PA, Biopool AB, Umeá, Sweden). 
Plasminogen activator inhibitor antigen (PAI-Ag) was assayed by an enzyme immunoassay, 
using anti-PAI antibodies (TintElize™ PAI-1, act. no. 210221, Biopool AB, Umeâ, Sweden). 
Activity of tissue-type plasminogen activator (t-PA-act) was assayed according to Verheijen 
et al. (18). Total u-PA-Ag, plasmin-activatable single-chain u-ΡΑ (scu-PA) activity and active 
two-chain u-ΡΑ (tcu-PA) were measured using a combination of an ELISA and a biological 
immunoassay and the activities were correlated with antigen levels through calibration 
(19,20). The lower detection limit in our material was 0.1 ng/ml. Fibrin degradation products 
(FbDP's) and fibrinogen degradation products (FgDP's) were determined together and 
separately in the peritoneal fluid with an enzyme immunoassay, Fibrinostika Microelisa 
system (Organon Teknika, Boxtel, The Netherlands). 
Medians and interquartile ranges were calculated for each parameter. The Mann-
Whitney-test was employed to test for differences between the PID group and the control 
group. 
The study was approved by the hospital ethical committee. 
RESULTS 
Laparoscopy in the patients with a provisional diagnosis of PID confirmed the 
diagnosis in all 10 patients. PID in the majority of patients were classified as moderate 
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(η = 7), one as mild and two as severe PID. Erythrocyte sedimentation rate of the PID 
patients ranged from 20 to 119 mm/lhr (mean 49.3, median 44), leucocytes ranged from 8.9 
to 27.6 .109/1. (mean 17.6, median 16.5). 
Cervical cultures showed Chlamydia in six patients and N. gonorrhoea in one patient. 
In most patients multiple species were found in the cervical cultures: Mycoplasma hominis, 
staphylococcus, streptococcus and anaerobic organisms: Bacteroides, peptococcus and 
peptostreptococcus. 
During laparoscopy of the patients in the control group no intraperitoneal 
abnormalities (adhesions, endometriosis etc.) were found. 
The haemoglobin concentration in the peritoneal fluid of the patients in the PID-group 
was less than 1.5 mmol/1 (0.8 - 1.4 mmol/1), of the women in the control-group less than 1.0 
mmol/1 (0.03 - 0.9 mmol/1). 
In the PID-group, PAI-Ag, t-PA-Ag, and u-PA-Ag in peritoneal fluid were 
significantly higher than in the control group (Table 5.1, page 79). The difference between 
the concentrations of plasma and peritoneal fluid t-PA-Ag and u-PA-Ag were highly 
significant (p < 0.0002), indicating production and accumulation of t-PA-Ag and u-PA-Ag 
in the peritoneal cavity in PID. There was no difference between the PID and control group 
with regard to t-PA-Act or scu-PA of peritoneal fluid. The concentrations of TDP and FbDP 
were significantly higher in the peritoneal fluid of patients with PID than in the control 
group. Active tcu-PA was not detectable in any of the samples. 
In plasma, u-PA-Ag was higher in the PID-group compared with the control group. 
PAI-Ag, t-PA-Ag and t-PA-Act in plasma showed no differences between both groups (Table 
5.2, page 80). 
Fibrinolytic parameters are represented in Figures 5.1 and 5.2 (page 81). 
DISCUSSION 
Our study shows that in peritoneal fluid of women with laparoscopically confirmed 
PID, PAI-Ag, t-PA-Ag, u-PA-Ag, TDP and FbDP are manifold higher than in the control 
group of women without PID, who underwent laparoscopy for sterilisation. The differences 
are statistically highly significant. 
Our observations seem to contradict the common opinion that fibrinolysis in peritonitis 
is reduced, mainly based upon the studies of Thompson et al. (21) and Vipond et al. (22), 
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who studied plasminogen activating activity (PAA) of normal and inflamed peritoneum. 
Using a fibrin plate technique, they found that biopsies or tissue homogenates of inflamed 
peritoneum had significantly less PAA compared with normal peritoneum. The concentration 
of t-PA-Ag, however, was not different from normal (22). Plasminogen activator inhibitor-1 
(PAI-1) was not present in control peritoneum, but was present in all samples of inflamed 
peritoneum (22). These studies seemed to corroborate studies in experimental animals, which 
had demonstrated that injury to the peritoneum impairs its fibrinolytic activity 
(9,10,11,23,24). 
In our study, t-PA activity of peritoneal fluid of patients with PID was not 
significantly different from the control group. Although the t-PA activity was not elevated, 
we demonstrated an accumulation of t-PA-Ag in peritoneal fluid of patients with PID. This 
suggests a high rate of local t-PA production. The rise in t-PA-Ag in peritoneal fluid of the 
PID patients - without a change in mean t-PA activity - can be explained by the assumption 
that the bulk of the t-PA-Ag is complexed to PAI and that its activity is quenched. The high 
level of PAI-1-Ag might represent complexed, inactive PAI. The t-PA might have displayed 
fibrinolytic effects before being complexed to PAI. However, even in the presence of high 
PAI activity, t-PA can display some intrinsic activity (25). Kooistra et al. provided evidence 
that plasma fibrinolytic activity was dependent on t-PA activity, rather than on PAI activity 
(26). If this holds true for closed compartments with a high turnover of fibrinolytic enzymes, 
this might explain the active intraperitoneal fibrinolysis in our PID patients with high 
peritoneal fluid concentrations of both t-PA-Ag and u-PA-Ag. Indeed, from the high levels 
of TDP and FbDP in the peritoneal fluid of the PID group, it can be inferred that the 
intraperitoneal fibrinolytic system had exerted a high activity. 
Parallel with the increase in t-PA-Ag in the peritoneal fluid of patients with PID, we 
found that the peritoneal fluid u-PA-Ag concentration was significantly higher in the PID 
group than in the control group. Although the scu-PA concentration was not increased and 
tcu-PA was not detectable, the high u-PA-Ag concentration suggests that most of the u-PA, 
that entered the peritoneal cavity in the form of scu-PA, had been converted to two-chain 
urokinase or to another form which is complexed to PAI-1. 
In vitro studies showed that production and release of t-PA and PAI is influenced by 
endotoxins and cytokines. Certain cytokines, e.g. the inflammatory mediator tumor necrosis 
factor, TNF, which is released from activated macrophages in areas of inflammation, induce 
a marked decrease in the production of t-PA and an increase in PAI production in cultured 
human omental mesothelial cells (27). Other studies have shown that local u-PA 
concentration rises during inflammation (28,29,30). In the inflamed peritoneum, the situation 
might be different. Van Hinsbergh et al. did not find any u-ΡΑ activity in cultured human 
omental tissue mesothelial cells (HOMC), neither production of u-ΡΑ after incubation of 
HOMC with TNF (27). Cytokines (TNF, lymphotoxin, interleukin-1), on the other hand, 
stimulate the production of u-ΡΑ by endothelial cells, in combination with synthesis and 
production of PAI-1. The u-ΡΑ appeared to be secreted mainly at the abluminal side of the 
cultured endothelial cells; in peritoneal capillaries this might result in an increase in the 
concentration of u-ΡΑ in the peritoneal fluid rather than in a rise in circulating u-PA (20). 
The combination of an increase in t-PA and an increase in u-PA should be explained by 
assuming different sources of the two plasminogen activators: u-PA from inflamed tissue 
endothelial cells (with leakage to the peritoneal fluid) and t-PA either from the peritoneum 
or from the fallopian tubes. Since there is an open communication from the uterus through 
the tubes to the peritoneal cavity, the fibrinolytic parameters measured in the peritoneal fluid 
may be influenced by an exudate from the fallopian tubes. Albrechtsen examined fibrinolytic 
activity of the peritoneal organs and found that fibrinolytic activity of the human uterus was 
the highest of all organs (31). Examination of fibrinolytic activity of the human fallopian tube 
by Astrup et al. revealed high concentrations of plasminogen activator in the mucosa and 
muscularis of the tube (32). Irritation of the uterus and tubes in women with PID might cause 
a stimulation of the fibrinolytic activity and a release of t-PA and PAI into the peritoneal 
cavity. Another explanation for the high fibrinolytic activity in our patients with PID could 
be that laparoscopy was performed just after the acute phase of the inflammation when 
fibrinolytic activity of the peritoneum was restored. Animal studies showed that peritoneal 
injuries depressed peritoneal fibrinolysis for several days. The time course of the return of 
fibrinolytic activity varied with different forms of peritoneal injury (33,34,35). 
A significantly higher plasma u-PA-Ag was found in the PID-group compared with 
the control group, but since the median values of both the control group and of the patient 
group were well within the range found in a larger group of healthy donors (19), we hesitate 
to attach any relevance to this finding. 
The classical concept of adhesion formation is that a reduction in mesothelial 
plasminogen activator activity prevents lysis of fibrinous adhesions and causes permanent 
fibrous adhesions. This concept is based on determination of fibrinolytic parameters of 
peritoneal tissue. We studied activators and inhibitors of fibrinolysis in peritoneal fluid and 
found evidence for an enhanced intraperitoneal fibrinolysis during PID. In order to 
understand the persistence of fibrin deposits and the formation of adhesions in some patients, 
we have to envisage the possibilities that the highly stimulated fibrinolysis is only a transient 
phenomenon, that during the infective process the enhanced fibrinolytic activity still does not 
meet the demand, or the circumstances for the proper action of plasmin are unfavourable. 
In other words, the fibrin production is larger than is compensated by the enhanced, plasmin-
induced fibrinolysis. The therapeutic answer would be the introduction of fibrinolytic agents 
in the abdominal cavity in spite of the high t-PA-Ag and u-PA-Ag. Animal studies show that 
application of t-PA to the peritoneal cavity prevents adhesion formation (36,37,38). This 
should be confirmed in other studies 
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Figure 5Л. Fibrinolytic parameters of peritoneal fluid in patients with PID (gray bars) and 
controls (hatched bars). The bars represent the interquartile range; the median value is 
indicated by a horizontal line. The antigen (Ag) concentrations are expressed in ng/ml, the 
t-PA activity in milliunits. The statistical significance of the differences are indicated: * = 
ρ < 0.002 ; ** = ρ < 0.0005 ; *** = ρ = 0.0002 ; N.S. = not significant. 
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Figure*5.2. Concentration of total fibrin and fibrinogen degradation products (TDP) and 
fibrin degradation products (FbDP) in peritoneal fluid of patients with PID and in control 
patients. Symbols are the same as in Figure 1. 
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CHAPTER 6 
PARAMETERS OF FIBRINOLYSIS IN PERITONEAL FLUID AND PLASMA OF 
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SUMMARY 
The objective of this study was to investigate pathogenesis of adhesions in 
endometriosis. The classical concept of the etiology of peritoneal adhesions is that 
intraperitoneal fibrinolytic activity is depressed in the early stage of adhesion formation. 
We examined parameters of fibrinolysis in peritoneal fluid and plasma of ten women 
with endometriosis. Eight women, in whom laparoscopy for sterilisation was performed, 
served as a control group. Peritoneal fluid and plasma were sampled in the first part of the 
menstrual cycle. 
There were no differences in t-PA-Ag, PAI-Ag, u-PA-Ag, scu-PA, TDP and FbDP 
concentrations between the endometriosis- and the control-group. In peritoneal fluid of 
women with endometriosis t-PA-Act was higher (p<0.05) and PAI-Act was depressed 
(61.5%). In plasma no differences were found. 
The increased t-PA-Activity does not suit with the classical concept of adhesion 
formation. 
INTRODUCTION 
The pathogenesis and etiology of endometriosis remain controversial despite extensive 
research into this subject. Major theories on this subject consider coelomic metaplasia and 
transplantation of exfoliated endometrium (1,2). 
The association between extensive endometriosis and infertility is clear since 
adhesions impair ovarian physiology and tubal ovum pick-up. The relation between 
endometriosis and infertility in the absence of distortion of pelvic anatomy remains to be 
established. 
Intraperitoneal adhesions are caused by laparotomies, inflammation or endometriosis. 
In areas of meso t hel i al injury fibrin is deposited and when intraperitoneal fibrinolysis is 
inadequate the fibrinous clot is organized by fibroblastic proliferation and deposition of 
collagen, resulting in permanent fibrous adhesions (3-5). 
It has been proposed that women with endometriosis have an altered peritoneal 
environment that interferes with fertility (6). Several authors have evaluated specific 
alterations in peritoneal fluid of women with endometriosis (6,7). The principal constituents 
in peritoneal fluid that have been studied in women with endometriosis are macrophages, 
prostaglandins, cytokines and proteins, such as plasminogen activators. 
The etiology of adhesions in endometriosis is unknown. Conflicting data about this 
subject have been published. Studies on plasminogen activator activity (PAA) of peritoneum 
and peritoneal fluid of patients with endometriosis show different results. PAA of 
endometriotic implants in women with endometriosis appeared in some studies to be 
decreased (8,9). Other studies did not find any difference in fibrinolytic parameters of 
peritoneal fluid in women with or without endometriosis (10,11,12,13). 
In a previous study we found differences between the first and second part of the 
menstrual cycle in fibrinolytic parameters of peritoneal fluid and plasma in women without 
intra-abdominal pathology (14). In this study we examine activators and inhibitors of 
fibrinolysis in peritoneal fluid and plasma of women with endometriosis and compare these 
data with fibrinolytic parameters in peritoneal fluid of women without intra-abdominal 
pathology in the same part of the menstrual cycle. 
MATERIAL AND METHODS 
Peritoneal fluid was obtained from patients at the time of diagnostic laparoscopy for 
evaluation of infertility. 
The selection criteria for these patients were as follows: 
no history of abdominal or vaginal operations, except uncomplicated appendectomy, 
regular menstrual cycle (23-32 days), 
no use of any medication, 
visual diagnosis of endometriosis during laparoscopy, 
patency of at least one tube. 
Endometriosis was classified according to the revised American Fertility Society (r.AFS) 
classification (15). Laparoscopy was performed in the follicular phase of the menstrual cycle. 
Eight patients, who underwent laparoscopy for sterilisation, served as a control group. 
The selection criteria for these patients were as follows: 
no evidence of any abdominal pathology, based on their preoperative history and 
physical examination, 
no history of abdominal or vaginal operations, except uncomplicated appendectomy, 
regular menstrual cycle (23-32 days), 
delivery of at least one live-born child, 
no use of any medication, including oral contraceptives, 
no IUD, 
not lactating, 
during laparoscopy no evidence of any intraperitoneal abnormality (adhesions, 
endometriosis). 
Laparoscopy was performed in the follicular phase of the menstrual cycle. 
The mean age of the women in the endometriosis group was 32 years (25-39 years), 
and of the women of the control group 33 years (29-36 years). 
Laparoscopy was performed under general anaesthesia. Peritoneal fluid was aspirated 
from the pouch of Douglas and vesicouterine space. A sample of peritoneal fluid was 
collected in 0.11 M tri sod i urn-citrate. The citrate tube was placed in melting ice and within 
90 min. centrifuged at 4°C, the supernatant was stored at -40'C. 
During laparoscopy, 10 ml. venous blood was sampled; 1.8 cc was collected in citrate 
and handled as mentioned above, the remainder was used for determination of estradiol and 
progesterone. 
Estradiol was measured with the Coat-Α-Count Estradiol RIA kit of DPC (Diagnostic 
Products Corporation, Los Angeles, USA). Progesterone was determined by the Amerlex-M 
Progesterone RIA kit (Kodak Clinical Diagnostics LTD Amersham UK). 
Tissue-type plasminogen activator antigen (t-PA-Ag) was assayed by an enzyme 
immunoassay, using anti-t-PA antibodies (Immulyse™ t-PA, Biopool AB, Umeâ, Sweden). 
The test measures both free and complexed t-PA. Plasminogen activator inhibitor antigen 
(PAI-l-Ag) was assayed by an enzyme immunoassay, using anti-PAI antibodies (Tint-Elize™ 
PAI-1, cat. No 210221, Biopool AB, Umeâ, Sweden). The test measures both free PAI-1 and 
PAI-1 complexed to activators. Activity of tissue-type plasminogen activator (t-PA-Act) and 
plasminogen activator inhibitor activity (PAI-Act) were assayed according to Verheijen et al. 
(16). Total urokinase type plasminogen activator antigen (u-PA-Ag), plasmin-activatable 
single-chain u-ΡΑ (scu-PA) and active two-chain u-ΡΑ (tcu-PA) were measured using a 
combination of an ELISA and a biological immunoassay and the activities were correlated 
with antigen levels through calibration (17,18). The lower detection limit in our material was 
0.1 ng/ml. Fibrin degradation products (FbDP) and fibrinogen degradation products (FgDP) 
were determined together (TDP) and separately in the peritoneal fluid with an enzyme 
immunoassay, Fibrinostika Microelisa system (Organon Teknika, Boxtel, The Netherlands). 
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Medians and interquartile ranges were calculated for each parameter. The Mann-
Whitney-test was employed to examine the differences between the endometriosis and the 
control group. 
The study was approved by the hospital Ethics Committee. 
RESULTS 
In the study group of ten women endometriosis was staged as minimal (r. AFS stage 
I) in six patients, as mild (r.AFS stage II) in one patient and as moderate (r.AFS stage III) 
in three patients. 
The serum estradiol level in the endometriosis group ranged between 0.10 - 0.91 
nmol/1, mean 0.35 nmol/1, median 0.29 nmol/1. The serum estradiol level in the control 
group ranged between 0.10-0.97 nmol/1, mean 0.39 nmol/1, median 0.32 nmol/1. 
Fibrinolytic parameters in peritoneal fluid and plasma are represented in table 6.1 and 
table 6.2 (page 91, 92). 
In peritoneal fluid of the endometriosis group t-PA-Act was significantly higher than 
in the control group (p=0.0404). There were no differences in t-PA-Ag, PAI-l-Ag, u-PA-
Ag, scu-PA and tcu-PA concentrations between the endometriosis and control group. PAI-Act 
in peritoneal fluid of the endometriosis group was decreased (median 61.5%, interquartile 
range 53-108%) compared with normal plasma levels. 
In plasma no differences were found in fibrinolytic parameters between the two 
examined groups. 
DISCUSSION 
The common opinion about pathogenesis of postoperative adhesions is that during the 
early phase of adhesion formation intraperitoneal PAA is depressed (5,6,7). The pathogenesis 
of adhesions in women with endometriosis has to be established. 
In a previous study we measured fibrinolytic parameters in peritoneal fluid of women 
without intra-abdominal pathology in the first and second part of the menstrual cycle (14). 
We showed that peritoneal fluid PAI-l-Ag was threefold higher in the post-ovulatory period. 
In plasma u-PA-Ag and scu-PA were 30% lower post-ovulatory. 
In this study we compared fibrinolytic parameters of peritoneal fluid of women with 
endometriosis with the same parameters of a control group of women without intra-abdominal 
pathology in the same (first) part of the menstrual cycle. According to the selection criteria 
used and the age distribution, both groups of women are comparable. 
In contrast to the previously mentioned studies on PAA of peritoneal fluid of women 
with endometriosis, we found that t-PA-Act of peritoneal fluid was significantly higher in the 
endometriosis group than in the control group. There were no differences regarding the other 
fibrinolytic parameters. The increase in t-PA-Act in peritoneal fluid of the endometriosis 
patients without an increase in t-PA-Ag or a decrease in PAI-l-Ag can be explained by the 
assumption that most of PAI is complexed to t-PA and u-ΡΑ and that peritoneal fluid PAI 
Activity is decreased in women with endometriosis. Therefore, we also measured PAI 
activity (PAI-Act) in peritoneal fluid of women with endometriosis. The peritoneal fluid PAI-
Act in these women was only 61.5 % as compared with normal plasma levels. It was not 
possible to assay PAI-Act in samples of peritoneal fluid of the control group due to lack of 
material for analysis. 
We did not find any differences in fibrinolytic parameters in plasma between the 
endometriosis and control group. 
The classic concept of decreased fibrinolytic activity as a cause of adhesion formation 
does perhaps not apply to adhesion formation in inflammation and endometriosis. Concerning 
intraperitoneal inflammation, some studies showed peritoneal tissue PAA to be reduced 
(19,20). In a previous report we found that during pelvic inflammatory disease (PID) PAA 
in peritoneal fluid was enhanced (21). In order to understand the formation of adhesions in 
PID, it might be that the fibrin production was increased and not compensated by the 
enhanced fibrinolysis. The peritoneal environment in the examined women with endometriosis 
looked unfavourable with regard to adhesion formation since t-PA-Act was high. One of the 
main problems in studying endometriosis is, that endometriosis has different macroscopical 
appearances with diverse histological characteristics and differences in biochemical activity 
(22). The r.AFS Classification System, as used for this study, includes only location, size 
and number of endometriotic implants (15). It is possible that endometriotic implants with 
different biochemical activity exert a different influence on fibrinolytic constituents of 
peritoneal fluid. Further research is needed to learn more about adhesion formation in 
endometriosis. 
Until now the transplantation theory of exfoliated endometrial cells is regarded as the 
most plausible theory of pathogenesis of endometriosis (23). Retrograde menstruation occurs 
in the majority of women with patent tubes (24). Viable endometrial cells from peritoneal 
fluid of women with open tubes adhere and proliferate in vitro in the early follicular phase 
(25). From early studies we know that both in the endometrium and myometrium of the 
uterus, and in menstrual blood plasminogen activator concentrations are high (26-28). The 
concentration of plasminogen activators in the endometrium appeared to be higher with 
excessive menstrual blood loss compared to women with normal menstruation (29). 
Plasminogen activators, especially u-ΡΑ, are important in extracellular proteolytic 
mechanisms with breakdown of extracellular matrix resulting in e.g. cellular migration, 
tumor invasion, ovulation, fertilization and trophoblast invasion (30). The enhanced t-PA 
activity in peritoneal fluid of women with endometriosis may be caused by the presence of 
plasminogen activator activity of the endometrium, the endometriotic implants or exfoliated 
endometrial cells. The increased t-PA activity may contribute to the invasion of endometrial 
cells into the intact peritoneum, and support the transplantation theory in this way. 
In conclusion, this study shows that t-PA-activity in peritoneal fluid of women with 
endometriosis is increased. The enhanced t-PA-Act does not correspond with the classical 
concept of adhesion formation. Plasminogen activator activity of the endometrium, the 
ectopic endometrial implants and exfoliated endometrial cells may cause the increased t-PA-
Activity in the peritoneal fluid. 
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SUMMARY 
The fibrinolytic system of the peritoneum is important in the pathogenesis of 
adhesions. Plasminogen activator activity is depressed by serosal types of injury, which cause 
ischemia. Ischemic peritoneum induces fibrinous adhesions. When local fibrinolytic activity 
is impaired, persistence of fibrin and organisation of the fibrinous adhesions may occur. 
Peritoneal adhesions in rabbits were created by drying the serosa of the uterine horns 
and by introducing a small amount of blood intraperitoneally. In one group of rabbits tissue-
type Plasminogen Activator (t-PA) was given intraperitoneally at the end of the operation; 
another group served as controls. Fortyeight rabbits were operated on. The animals were 
sacrified 3 hours, 1, 3 and 7 days postoperatively for evaluation of adhesions. All animals 
of the control group had adhesions. The animals of the t-PA group had less adhesions than 
the animals of the control group. 
INTRODUCTION 
Mesothelial damage may cause adhesions. Peritoneal injuries induce an inflammatory 
exudate, which is rich in fibrinogen and coagulates within a few hours. Normally, the 
majority of fibrinous attachments are lysed within a few days. If the fibrinous exudate 
persists, organisation by ingrowth of fibroblasts and capillaries may occur, causing permanent 
adhesions (1). There are many causes of mesothelial damage, e.g. any laparotomy may cause 
adhesions (2). Intestinal obstruction is the most common complication of intraperitoneal 
adhesions (3-5). The most common causes of adhesions in the small pelvis of women are 
peritonitis of infectious origin, endometriosis and surgical procedures. Adhesions in the small 
pelvis may impair fertility. Nature, location and extent of adhesions determine their possible 
interference with normal fertility (6-8). 
Tissue ischemia is an important factor in the aetiology of adhesions (9). 
Ryan and associates (10) described an experimental model of peritoneal adhesions in 
the rat, based on two accidents, that may occur during abdominal surgery: drying of the 
serosa and blood. Drying plus blood consistently produced adhesions in the dried area. 
Peritoneal injury decreases fibrinolytic activity of the peritoneum and this may cause 
permanent adhesions, because the fibrinous exudate cannot be lysed (11-13). 
There are many possibilities to prevent adhesion formation. Promoting lysis of fibrin 
is one of these (14). 
The aim of our study was to verify whether tissue-type plasminogen Activator (t-PA) 
could prevent adhesions, using the experimental model of Ryan et al (10). Until now, a great 
deal of research has been performed using plasminogen activators streptokinase and urokinase 
with different results. t-PA has several advantages as compared with streptokinase and 
urokinase. It is not antigenic and thus will not cause allergic reactions, it is absorbed in 
particular onto fibrin clots, displays its effects only there and even when introduced into the 
circulating blood it has little or no general side effects in blood coagulation (15). When 
sufficient amounts of t-PA are present in the blood during coagulation, the resulting clot will 
lyse rapidly (16). This principle is applied in our approach to prevent adhesions. 
MATERIALS AND METHODS 
Forty eight female non pregnant New Zealand white rabbits were used for the study. 
The weights of the rabbits varied between 2 an 3 kgs. Induction of anaesthesia was achieved 
with 1 ml. fluonisone plus phentanyl citrate ( HypnormR) and 0.25 mg. atropine and 
maintained with a mixture of 02, N 20 and 2% fluothane. The abdomen of the rabbits was 
shaved and antiseptically cleansed and draped. A laparotomy by midline incision was 
employed. Both uterine horns were placed on a dry gauze, the rest of the abdomen being 
covered with gauzes moistened with 0,9% NaCl. During 10 minutes the uterine horns were 
dried by an electrical heater. Temperature during drying at the level of the uterine horns was 
50° С After drying 5 ml. of blood were obtained by puncturing the aorta. This blood was 
left behind in the peritoneal cavity. The abdomen was closed using Polyglactin-910 (VicrylR). 
Four groups of six rabbits were operated on in this way. After 3 hours, 1, 3 and 7 
days a second laparotomy was performed. Adhesions were described and staged. The uterine 
horns were removed, fixed in formalin 4% and examined histologically. Another four groups 
of six rabbits were operated on in the same way. In addition to 5 ml of blood, 50 μΐ of a 
solution of t-PA was left behind in the peritoneal cavity. Both the extent and nature of 
adhesions were rated and rarings were done by one of the authors, who did not know 
whether the rabbits had received t-PA or not. Table 7.1 (page 99) shows the staging system 
of adhesions. 
T-PA was obtained from Kluft (17). One ml solution contained 0,10 mg t-PA or 
47610 IU t-PA. The medium consisted of 0,01 M NaPi, 0,15 M NaCl and 0,01% Tween 
95 
80, pH 7.5. The medium that was left behind in the peritoneal cavity (50/d) contained 2380,5 
IU t-PA. 
The Wilcoxon test was employed to test for differences in adhesions scores. 
RESULTS 
Table 7.2 (page 99) summarizes the results of our study. At all times the t-PA groups 
showed less adhesions than the control group, the p-values being: 3 hours, 0,004; 1 day, 
0.008; 3 days, 0.007; 7 days, 0,06. One rabbit in the t-PA group died before the second 
laparotomy as a result of an infection. 
DISCUSSION 
The rabbit is the animal of preference for research in adhesions. Compared to other 
animals the fibrinolytic activity of its tissues is low. Therefore in rabbits tissue damage can 
easily cause adhesions (18). 
The fibrinolytic capacity of peritoneum resides in plasminogen activators, present in 
both the mesothelium and in submesothelial bloodvessels (11,18,19). These activators convert 
plasminogen, present in blood and fibrinous exudates, into plasmin, a fibrinolytic enzyme. 
The decrease in fibrinolytic activity as a result of peritoneal injury is an important factor in 
induction of permanent adhesions (11-13). If fibrinolysis is inadequate, fibroblastic migration 
and proliferation in the inflammatory fibrinous exudate may occur, causing permanent 
adhesions (20). It is therefore logical to try to prevent permanent adhesions with fibrinolytic 
agents, such as plasminogen activators in order to promote the removal of fibrin depositions. 
In the past a great deal of research has been done on this subject. Using different fibrinolytic 
agents, Fibrinolysin (21-25), streptokinase (26-28), and urokinase (11,29), varying results 
were obtained. The treatment programs are hard to compare, since different animals, 
different methods of inducing adhesion formation, and different routes of administration and 
dosages of the fibrinolytic agents were used. In our experimental model, induction of 
adhesions is easily standardized. t-PA has recently been available and has certain advantages 
over other plasminogen activators as has been mentioned earlier. In the control group, all 
rabbits, except one, showed adhesions. Most adhesions were seen after one day, both in the 
t-PA and in the control groups. Apparently spontaneous resorption of adhesions occurred 
after one day. This corresponds with the observations of Raftery (30) in the rat. He found, 
that after peritoneal injury, fibrinolytic activity was absent for two days, but then gradually 
increased. Pathological examination showed fibroblasts in the adhesions, which were present 
after 1 week. This is in accordance with the literature (1). 
It is not to be expected, that after fibroblastic migration and proliferation adhesions 
will disappear spontaneously. Possibly, early lysis of fibrin in bloodclots and inflammatory 
exudates prevents the ingrowth of fibroblasts, although transient adhesions are formed. 
In conclusion, it is possible to prevent permanent adhesions by introducing t-PA into 
the peritoneal cavity after surgical intervention. Continued research is performed in the use 
of t-PA for adhesion prevention. 
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Table 7.1 
CLASSIFICATION OF ADHESIONS 
Extent of adhesions 
- No adhesions О 
- Less than 50% of the uterine horns showed adhesions I 
- Over 50% of the uterine horns showed adhesions II 
- The whole of the uterine horns showed adhesions III 
Nature of adhesions 
- No adhesions О 
- Filmy, easily separated adhesions A 
- Dense, fixed adhesions В 
Table 7.2 
Adhesions after 3 hours 
t-PA group Control group 
0 
0 
IA 
0 
0 
0 
IIA 
HA 
IA 
IIA 
IIA 
ША 
p= 0.004 
Adhesions after 3 days 
t-PA group Control group 
0 
IA 
0 
0 
0 
0 
IA 
IA 
IA 
IA 
HA 
IIIA 
p= 0.007 
Adhesions after 1 day 
t-PA group Control group 
IA IIIA 
IA IIIA 
IIIA IIIA 
IA IIIA 
IA IIIA 
IA IIIA 
p= 0.008 
Adhesions after 1 week 
t-PA group Control group 
IA 0 
0 IIA 
0 IIIA 
0 IA 
+ IIA 
IA IIIA 
p= 0.06 
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SUMMARY 
Mesothelial injuries depress local fibrinolytic activity which may result in permanent 
adhesions. Peritoneal adhesions may cause intestinal obstruction and infertility in women. 
In the rabbit we have minimized the formation of adhesions by promoting fibrinolysis 
using tissue-type plasminogen activator (t-PA). 
The objectives of this study were to examine mesothelial healing with and without t-
PA and to describe the origin of new mesothelium. 
We created mesothelial damage and adhesions in the rabbit by drying the serosa and 
introducing blood intraperitoneally. 
T-PA did not affect mesothelial healing; mesothelial healing was completed in seven 
days in both the t-PA and the control group. Tissue reaction was less severe in the group of 
rabbits exposed to t-PA than in the control group. 
Light microscopical and immunohistochemical evaluation showed that during 
mesothelial healing a proliferation of fibroblastoid cells occurred in the submesothelial tissue 
and at the wound surface. Electron microscopically these cells showed characteristics of 
mesothelial cells. The characteristics and location suggest that these fibroblastoid cells are 
the precursors of mesothelial cells. 
INTRODUCTION 
Peritoneal injury causes a loss of mesothelium and an inflammatory response from 
the mesothelial surface with outpouring of serofibrinous exudate. This exudate coagulates 
within a few hours (1). When the fibrinolytic capacity of the peritoneum is adequate fibrin 
is lysed and mesothelial repair occurs. When peritoneal fibrinolytic activity is inadequate, 
persistence of fibrin may occur, resulting in permanent adhesions by organization through 
proliferation of fibroblasts and formation of collagen (2,3,4). 
The most common causes of adhesions in women are abdominal surgery, infection 
and endometriosis. Peritoneal adhesions in women may impair fertility (5). intestinal 
obstruction is another wellknown complication of intraperitoneal adhesions (6). 
In this study we used an experimental model, described by Ryan et al (7), to create 
mesothelial damage and adhesions. This model is based on two accidents that may occur 
during abdominal surgery: drying of the serosa and the presence of blood. In a earlier study 
on adhesion prevention, performed in the rabbit, we have shown that drying the serosa and 
blood consistently produced adhesions. The formation of adhesions could be minimized by 
promoting fibrinolysis using tissue-type plasminogen activator (t-PA) intraperitoneally (8). 
The first aim of the present study was to show the light microscopical aspects of 
mesothelial repair with and without t-PA exposure. 
There are different opinions concerning the mechanism of mesothelial repair and the 
origin of new mesothelial cells. Circulating precursors, mature and immature mesothelial 
cells, peritoneal macrophages and connective tissue cells have all been postulated as the 
source of new mesothelial cells (9). 
The second aim of our study was to search the origin of mesothelium as evaluated 
by light and transmission electron microscopy and immunohistochemical examinations. 
METHODS 
Forty-eight female η on-pregnant New Zealand white rabbits were used for the study. 
The weights of the rabbits varied between 2 and 3 kg. Induction of anaesthesia was achieved 
with 1 ml. fluonisone plus phentanyl citrate (HypnormR) and 0.25 mg atropine, and 
maintained with a mixture of 02, N 20 and 2% fluothane. The abdomen of the rabbits was 
shaved and antiseptically cleansed and draped. A laparotomy by midline incision was 
performed. Both uterine horns were placed on a dry gauze, the rest of the abdomen being 
covered with gauzes moistened with 0.9% NaCl. For 10 minutes the uterine horns were dried 
by an electric heater. The temperature at the level of the uterine horns while drying was 
50°C. After drying 5 ml of blood were obtained by puncturing the aorta. This blood was left 
behind in the peritoneal cavity. The abdomen was closed using PolygIactin-910 (Vicryl*). 
Four groups of six rabbits (the control group) were operated on in this way. After 3 
h, 1, 3 or 7 days, a second laparotomy was performed. The adhesions were described and 
staged. The uterine horns were removed for histological examination. Another four groups 
of six rabbits (the t-PA group) were operated on in the same way. In addition to 5 ml of 
blood, 50μ1 of a solution of t-PA was left behind in the peritoneal cavity. 
t-PA was kindly donated by Dr Kluft of the Gaubius laboratory (10). One ml of 
solution contained 0.10 mg t-PA or 47610 IU t-PA. The medium consisted of 0.01 M NaP„ 
0.15 M NaCl and 0,01% Tween 80, pH 7.5. The medium that was left behind in the 
peritoneal cavity (50 μΐ) contained 2380.5 IU t-PA. 
Tissues for light microscopy were fixed in formalin 4%, specimens were embedded 
in paraffin. Sections were stained with haematoxylin and eosin (H&E) and azan. Light 
microscopical examination of H&E and azan sections focused on a qualitative analysis of 
fibrin depositions, infiltration of blood cells, vascular reaction and mesothelial precursor 
cells. 
Formal in-fixed and paraffin-embedded tissues were studied immunohistochemically 
by using monoclonal antibodies: Vimentine (Dakopatts, Denmark) specific for tissues of 
mesenchymal differentiation, EMA (epithelial membrane antigen, Dakopatts, Denmark) and 
CAM-5.2 (pankeratin, Becton and Dickinson, USA), specific for tissues of epithelial 
differentiation. 
For Transmission Electron Microscopy (ТЕМ) tissue fragments of 0.5 mm3 were 
immersion-fixed by incubation in 1.5 % glutaraldehyde in 0.1 M cacodylate buffer, pH 7.3, 
for 20 minutes, followed by postfixation in 1 % Os04, dehydration in ethanol and embedding 
in Epon 812. Ultrathin sections were cut on a Reichert Om-U3 ultramicrotome and 
photographed in a Philips CM 10 electron microscope. 
RESULTS 
To analyze the effect of t-PA on mesothelial repair, we studied mesothelial healing 
three hours, and one, three and seven days after the first laparotomy. 
At three hours mesothelium had partly disappeared. The surface of the peritoneum 
was covered with fibrin (Fig 8.1, page 109). The submesothelial blood vessels showed 
dilatation and margination of white blood cells, mainly polymorphonuclear leucocytes. There 
was some migration of polymorphonuclear cells in the submesothelial tissues. The tissue 
reaction was generally the same in the control and the t-PA group. 
On day one the wound surface was covered with a fibrinous exudate containing fibrin 
through which were white blood cells, mainly polymorphonuclear cells, but also 
macrophages. Submesothelial tissue showed dilatation of blood vessels and migration of 
polymorphonuclear cells and macrophages. The reaction in the control group was much more 
pronounced than in the t-PA group. 
On day three fibrin was still present at the wound surface. Macrophages infiltrated 
the fibrinous exudate. A proliferation of spindle-shaped fibroblastoid cells became evident 
both at the submesothelial side and at the surface of the fibrinous exudate (Fig 8.2, page 
109). This phenomenon had a patchy pattern. It was remarkable that clots, unconnected with 
the uterus, were organized from the outside with fibroblastoid cells. After three days the 
overall tissue reaction was also more pronounced in the control group than in the t-PA group. 
On day seven fibrin had disappeared. Most of the wound surface was covered with 
new mesothelial cells with a marked submesothelial proliferation of the spindle-shaped 
fibroblastoid cells. 
To examine the origin of the mesothelial precursor cells we compared the light 
microscopical findings with the immunohistochemical and ТЕМ observations. 
The fibroblastoid cells were positive for Vimentine and did not react with EMA or 
CAM-5.2. Using ТЕМ, observations were made on the third and seventh days, when the 
spindle-shaped fibroblastoid cells were identified by light microscopy. The wound surface 
was covered by cells with mesothelial appearances: microvilli, tight junctions and pinocytotic 
vesicles. Besides the mesothelial cells which partly covered the wound surface, cells of 
another appearance were recognized. They were located, as seen by light microscopy, both 
at the submesothelial side and at the wound surface. These cells were both rounded and 
elongated, had a high electrolucent cytoplasm with pinocytotic vesicles. At the wound 
surface, they showed some microvilli and when located submesothelially they were 
surrounded with extracellular matrix mainly consisting of collagen fibers (Fig 8.3, page 110). 
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DISCUSSION 
Our study shows that the kind of tissue reaction in the control group was similar, but 
more pronounced than in the t-PA group. The more pronounced reaction in the control group 
corresponds well with our macroscopical findings that this group showed more adhesions than 
the t-PA group. On day seven mesothelial healing was completed both in the t-PA and in the 
control group. 
Concerning the origin of the mesothelium, our study shows a proliferation of 
fibroblastoid cells. Immunohistochemical examination demonstrates a mesenchymal origin 
of these cells (Vimentine positive). With ТЕМ these cells show characteristics of mesothelial 
cells (11). 
Different hypotheses have been proposed as explanation of mesothelial healing. There 
is general agreement that healing of large peritoneal defects takes the same time as healing 
of small areas of damaged peritoneum. Unlike healing of squamous epithelium which starts 
from the wound edges and proceeds to the centre of the defect, peritoneal healing takes place 
simultaneously throughout the whole damaged area. 
Older studies suggested that new serosa is formed by proliferation of undamaged 
peritoneum at the margins of the peritoneal defect and by transformation of fibroblasts which 
migrated upwards from the base of the wound (12,13). Cameron et al. (14) considered the 
possibility that mesothelial cells were detached from nearby peritoneum and became 
implanted on the wound surface and acted as grafts. Other studies showed that monocytes 
and macrophages were transformed into mesothelial cells (15,16). 
It seems likely that a population of free-floating cells has a role in peritoneal healing. 
Eskeland (15) has demonstrated that a diffusion chamber placed in the peritoneal cavity of 
the rat, having no possible contact with the peritoneum, was covered by cells with the 
appearance of typical fibroblasts and proliferating mesothelium. 
Ellis et al. (17) concluded that the fibroblast was the most important source of the re-forming 
peritoneal membrane. Eskeland and Kjaerheim (18) in an electron microscopical study of 
the rat, concluded that peritoneal macrophages are transformed to fibroblasts and that 
mesothelial cells may be differentiated from fibroblasts, which were located in the most 
superficial layer. Venables et al (19) showed that local irradiation of peritoneal defects 
produced inhibition of local fibroblast proliferation without delay in the normal rapid healing 
of peritoneal mesothelium. They considered this as a strong evidence against the fibroblast 
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origin of mesothelium and believed that reconstitution of the peritoneal membrane was due 
to free-floating cells in the peritoneal fluid. 
Raftery (20) demonstrated in an electron microscopical study, that the new mesothelium arose 
from subperitoneal connective tissue cells, although it was unclear which particular cell line 
was involved. 
Whitaker and Papadimitriou (9) found, using Scanning and Transmission Electron 
Microscopy, that in the early stages of peritoneal healing macrophages occupy the wound 
surface. Those macrophages may phagocytose fibrin and cell debris and supply plasminogen 
activators to prevent adhesions. Mesothelial proliferation at the wound edges and the 
opposing peritoneal surface was followed by ingrowth of isolated immature mesothelial cells, 
migrating from the wound edge and the opposing serosal surface throughout the peritoneal 
wound. At two and three days they found, using electron microscopy, cells of varying shape 
of low electron density (LED cells). They concluded that these LED cells were in fact 
immature mesothelial cells. 
As found in our study, mesothelial healing starts with the appearance of macrophages 
on the wound surface. These phagocytotic cells are responsible for clearing the traumatic 
debris on the wound surface. It is doubtful whether peritoneal macrophages are precursor 
cells for new mesothelium. Raftery (21) labelled peritoneal macrophages with polystyrene 
spheres and showed that no polystyrene spheres could be seen in fibroblasts or in flattened 
cells of the superficial layer. Furthermore, peritoneal macrophages are "end cells" and it is 
unlikely that these cells will transform to another cell, e.g. a mesothelial cell (22). 
The precursor cells coming from the mesothelium may originate from the wound edge 
or the opposing surface, in which zones mitotic activity has been found by previous 
investigators (9,23). Because both large and small peritoneal defects heal at the same rate, 
healing of peritoneum by mesothelial precursor cells could occur by migration of mesothelial 
cells from the wound edges, from the opposite surface or from a population of viable 
mesothelial cells in the peritoneal fluid (9,16). In our experimental model we were not able 
to demonstrate mitotic activity of mesothelial cells. 
The location of the fibroblastoid cells, as we demonstrated in our study, suggests that 
their jorigin is in sub mesothelial cell layers and from the peritoneal cavity. It remains unclear 
from which cell-line the fibroblastoid cells originates. Our immunohistochemical 
examinations suggest a mesodermal origin. Theelectronmicroscopical characteristics of these 
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cells resemble the LED cells, described by Whitaker et al (9) except that the cells we found 
had less cytoplasm than the LED cells. 
In conclusion, t-PA exerted no negative influence on peritoneal healing. This is in 
accordance with other examinations with fibrinolytic agents (24,25). These results suggest 
that the use of t-PA in clinical studies is justified in order to prevent adhesions. Furthermore, 
it seems possible that there are precursor cells, located in the submesothelial or mesothelial 
tissue, with fibroblastic and mesothelial characteristics, which can transform into mature 
mesothelial cells. These cells may cover the damaged area by proliferation from the base of 
the wound and/or arrive in the peritoneal fluid and cover the mesothelial defect from the 
outside, growing as a monolayer which may fully cover the mesothelial wound. 
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Figure 8.1. Tissue reaction after three hours. Mesothelium has partly disappeared. The wound 
surface is covered with fibrin, in which erytrocytes and degenerated mesothelial cells (-► ) 
are present (Obj. 25x).
Figure 8.2. Tissue reaction after three days. There is a marked proliferation of fibroblastoid 
cells (-*-) both at the the wound surface and in the underlying connective tissue (Obj 25x).
r t  « nw * —
• /  '  *
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Figure 8.3. Electronmicroscopic photograph (x 3600) of tissue reaction after three days. 
Note the mesothelial cells with microvilli at the wound surface. The underlying cells (-*-) 
posses the same nuclear and cytoplasmatic features but do not show microvilli and are 
surrounded by collagen fibers.
CHAPTER 9 
GENERAL DISCUSSION 
Intraperitoneal adhesions are very common in men and women (1). The most common 
causes of intraperitoneal adhesions in women are abdominal surgery, infection and 
endometriosis. The classic concept of the pathogenesis of post-operative adhesions is as 
follows. Peritoneal injury causes loss of peritoneum and an inflammatory response from the 
damaged peritoneal surface with effusion of a serofibrinous exudate. This exudate coagulates 
within a few hours (2). When the fibrinolytic capacity of the peritoneum is adequate, fibrin 
is lysed and mesothelial repair occurs without adhesion formation. When the damage to the 
peritoneum is such that the fibrinolytic capacity of the peritoneum is inadequate, persistence 
of fibrin may occur, the fibrinous clot becoming organized within four to five days through 
proliferation of fibroblasts and formation of collagen, resulting in permanent fibrous 
adhesions (3-6). As in post-operative adhesions, the common opinion on the pathogenesis of 
adhesions in peritonitis is that reduction of the fibrinolytic activity of peritoneum causes their 
formation (7-9). The etiology of adhesions in endometriosis is still unknown (10). 
Intestinal obstructions are mainly caused by adhesions. Pelvic adhesions may also 
cause infertility in women by impeding ovum and embryo transport (11). The association 
between adhesions and infertility is not a clear-cut one. It may also be determined by the 
underlying disease which caused adhesion formation. 
The relation between adhesions and pain is also not obvious. Lysis of adhesions does 
not always result in the relief of pain. Most studies on adhesions and pain restrict themselves 
merely to somatic aspects and do not consider integrated pain models. 
Despite all the research performed on the prevention of adhesions, it is still not 
possible adequately to avert their formation. The main objective of the present study was to 
acquire more knowledge of the pathogenesis of adhesions and in particular on the relationship 
between fibrinolysis and adhesion formation, in order to present recommendations on 
adhesion prevention. 
Since the sixties, research has been performed in the field of fibrinolysis in relation 
to adhesion formation and prevention. Most studies refer to post-operative adhesion formation 
and rarely to other important causes of adhesions in women: pelvic inflammatory disease 
(PID) and endometriosis. The now classic concept of decreased fibrinolytic activity as a 
cause of adhesion formation is based on determination of fibrinolytic parameters of peritoneal 
tissue. 
In only a few studies has the fibrinolytic activity of peritoneal fluid been analyzed. 
In our studies we have examined activators and inhibitors of fibrinolysis in peritoneal fluid. 
Firstly, we examined fibrinolytic parameters of peritoneal fluid in different stages of the 
menstrual cycle and secondly we sought to identify conditions favouring adhesion formation 
in women with PID and endometriosis. 
The fibrinolytic activity of peritoneal fluid and plasma is influenced by a variety of 
factors. In earlier studies it appeared that some fibrinolytic parameters of peritoneal fluid are 
influenced by the stage of the menstrual cycle (12,13). Our conclusion is that the 
intraperitoneal fibrinolytic capacity may be impaired during the second part or luteal phase 
of the menstrual cycle, thereby enhancing the risk for post-ovulatory adhesion formation. 
Further research should be directed to consideration of the stage of the menstrual cycle in 
relation to adhesion formation and prevention. This could lead to recommendations on the 
phase of the menstrual cycle during which elective surgery should be performed. We also 
measured fibrinolytic parameters in plasma in the first and second part of the menstrual cycle 
and were surprised to find that some urokinase parameters are lower post-ovulatory. The 
influence of the menstrual cycle on urokinase-type plasminogen activator (u-ΡΑ) levels in 
plasma is the subject of a current longitudinal study. 
In women with PID, we demonstrated that the fibrinolytic activity of peritoneal fluid 
was enhanced through stimulation of the local production of tissue-type plasminogen activator 
(t-PA) and u-ΡΑ. In peritoneal fluid of women with endometriosis, tissue-type plasminogen 
activator activity (t-PA-Act) was higher than in the control group. Our data of fibrinolytic 
parameters in peritoneal fluid of women with PID and endometriosis are in contrast with the 
classic concept of decreased fibrinolytic activity as a cause of adhesion formation. This 
classic concept, however, was mainly based on measurements of fibrinolytic parameters in 
peritoneal tissue, while we performed our assays in peritoneal fluid. Considering the 
enhanced fibrinolytic activity of peritoneal fluid, the level of fibrinolytic enzymes in 
peritoneal fluid may have been influenced by the fibrinolytic activity issuing from the uterus 
and tubes. Previous studies have shown high concentrations of plasminogen activators in the 
endometrium, the myometrium and fallopian tubes (14-16). To understand the formation of 
adhesions in women with PID, we put forward the hypothesis that the enhanced fibrinolysis 
is insufficient to neutralize stimulated coagulation. Therapeutic enhancement of fibrinolysis 
by intraperitoneal introduction of fibrinolytic agents, e.g. t-PA, should therefore be 
considered. 
More investigations are necessary to identify the mechanisms of adhesion formation. 
Examination of the plasminogen activators and inhibitors of the uterus and fallopian tubes and 
the influence of the fibrinolytic activity of the uterus and tubes on the intraperitoneal 
fibrinolysis is required. Future research should also concentrate on analyzing fibrinolytic 
parameters of plasma, peritoneal tissue and peritoneal fluid to define their mutual influences 
and the relevance of each parameter. 
Following the classic concept of adhesion formation, it is logical to try to prevent 
their formation by applying plasminogen activators. Fibrinolysis streptokinase and urokinase 
have been used with varying results. 
Creation of a condition favorable for adhesion formation was achieved in an 
experimental model in rabbits. The method was based on the introduction of two accidents 
similar to those which may occur during abdominal surgery: drying of the peritoneum and 
the presence of blood. In this rabbit model we showed that it was possible to minimize 
adhesion formation by intraperitoneal administration of t-PA. The prevention of adhesions 
with t-PA has also been confirmed in other animal studies (17,18). 
In another study using the rabbit, we have shown that t-PA did not adversely affect 
mesothelial healing. We have also studied the origin of mesothelial cells. Through light 
microscopical and immunohistochemical examination during mesothelial healing, a 
proliferation of fibroblastoid cells was observed in the submesothelial tissue and at the wound 
surface. Electronmicroscopically, these cells showed characteristics of mesothelial cells. We 
concluded that these fibroblastoid cells may be the precursors of new mesothelial cells. These 
data justify the development of a clinical trial using t-PA to prevent adhesions. 
From our studies presented here, the following conclusions appear justified: 
There is evidence that the risk for adhesion formation in women is enhanced during 
the second half of the menstrual cycle. 
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When interpreting data on plasma u-ΡΑ levels in women, the stage of the menstrual 
cycle should be taken into consideration. 
Clearly, there is no unifying concept of adhesion formation. The mechanisms of 
adhesion formation post-operatively, in inflammation and in endometriosis are 
apparently different. 
The introduction of t-PA in clinical studies is justified. 
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SUMMARY 
Chapter 1 outlines the history of research into the pathogenesis and prevention of 
abdominal adhesions. The conclusion is that, in spite of the enormous number of reports 
written about adhesions, we are still far from understanding all the etiological aspects of 
adhesion formation and it is still not possible to prevent these adequately. The objectives and 
outline of the thesis are defined. 
Chapter 2 describes the prevalence of peritoneal adhesions and the relationships 
between adhesions and pain, intestinal obstruction and infertility. The literature on the 
pathogenesis of adhesions is reviewed. A synopsis is given of the field of fibrinolysis and 
some fibrinolytic assays, as we used in this study, are described. 
In Chapter 3 a survey is given on the literature of the prevention of adhesions. 
Various methods of adhesion prevention are discussed: limitation of peritoneal injury, 
inhibition of the inflammatory response, prevention of coagulation of fibrinogen, removal of 
fibrin and mechanical separation of injured mesothelial surfaces. 
Chapter 4 examines the differences in fibrinolytic activity in peritoneal fluid and 
plasma of women in the first and second part of the menstrual cycle. We measured 
fibrinolytic parameters in peritoneal fluid and plasma in eight women in the pre-ovulatory 
period and in eleven women in the post-ovulatory period of the menstrual cycle. 
There were no differences in fibrinolytic parameters in peritoneal fluid between the 
pre- and post-ovulatory group, except for PAI-l-Ag, TDP and FbDp. Contents of PAI-l-Ag, 
TDP and FbDP in peritoneal fluid were three-fold higher in the post-ovulatory phase 
(p<0.05). In plasma, u-PA-Ag and scu-PA concentrations were significantly lower (30%, 
ρ < 0.05) in the post-ovulatory phase and also lower than plasma u-PA-Ag and scu-PA 
(measured in the same assay) in a group of 50 healthy individuals. 
It was concluded that the intraperitoneal fibrinolytic capacity seems reduced during 
the second part of the menstrual cycle, leading to an increased risk for adhesion formation 
in the post-ovulatory period. The low plasma u-PA-Ag and scu-PA levels may also be 
clinically relevant. 
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In chapter 5 we describe the measurement of fibrinolytic parameters in peritoneal 
fluid and in plasma of 10 women with PID. Nine women, in whom laparoscopy for 
sterilisation was performed, served as a control group. 
In the peritoneal fluid of women with PID, PAI-Ag, t-PA-Ag and u-PA-Ag were 
many times higher than in the control group. T-PA activity and plasmin-activatable scu-PA 
were not significantly different in the two groups, whereas tcu-PA was not detectable. 
Nevertheless, the mean concentrations of peritoneal fluid TDP and FbDP were about twenty 
times higher in the PID group than in the control group. In plasma of PID patients, all 
parameters except u-PA-Ag were equal to those of the control group. 
Therefore, these data indicate an enhanced intraperitoneal fibrinolysis during 
peritoneal inflammation through stimulation of the local production of t-PA and u-ΡΑ. This 
is in contrast to the classic concept of decreased fibrinolytic activity as a cause of adhesion 
formation. Despite concomitant production of PAI, fibrinolysis definitely occurs, resulting 
in high levels of fibrin degradation products. Since this activated fibrinolysis apparently does 
not meet the demand, therapeutic enhancement should be considered as a means of preventing 
adhesions. 
In chapter 6 we examined parameters of fibrinolysis in peritoneal fluid and plasma 
of ten women with endometriosis. Eight women, in whom laparoscopy for sterilisation was 
performed, served as a control group. 
In peritoneal fluid of women with endometriosis, t-PA-Act was higher than normal 
(p<0.05), whereas PAI-Act was depressed (61.5%). There were no differences in the other 
fibrinolytic constituents of peritoneal fluid. In plasma no differences were found. 
The enhanced t-PA-Act in peritoneal fluid may have been caused by plasminogen 
activator activity of the endometrium, the ectopic endometrial implants and/or the exfoliated 
endometrial cells. The increased t-PA-Act does not conform to the classic concept of 
adhesion formation. 
In chapter 7, prevention of postoperative adhesions in the rabbit by local application 
of t-PA was examined . Peritoneal adhesions were created by drying the serosa of the uterine 
horns and by introducing a small amount of blood intraperitoneally. In one group of rabbits 
t-PA was given intraperitoneally at the end of the operation while another group served as 
controls. Each group consisted of 24 rabbits. Groups of six animals were sacrified at 3 hours 
and 1, 3 and 7 days after operation for evaluation of adhesions. All animals in the control 
group had adhesions. The t-PA group rabbits had less extensive adhesions. In conclusion, it 
is possible to prevent adhesions by introducing t-PA in the peritoneal cavity after surgical 
intervention. 
In chapter 8 mesothelial healing was examined in the absence or presence of 
exogenous t-PA and the formation of new mesothelium was described. We created 
mesothelial damage and adhesions in the rabbit by drying the serosa and introducing blood 
intraperitoneally. 
T-PA did not affect mesothelial healing; mesothelial healing was completed in seven 
days in both the t-PA and the control group. Tissue reaction was less pronounced in the 
group of rabbits exposed to t-PA than in the control group. 
Light microscopical and immunohistochemical evaluation revealed that a proliferation 
of fibroblastoid cells occurred in the submesothelial tissue and at the wound surface during 
mesothelial healing. Electronmicroscopically, these cells showed characteristics of 
mesothelial cells. The characteristics and location suggested that these fibroblastoid cells are 
precursors of mesothelial cells. 
Chapter 9 presents the following conclusions of our studies: 
There is evidence that the risk for adhesion formation is enhanced in the second half 
of the menstrual cycle. 
When interpreting data on plasma u-ΡΑ levels in women, the stage of the menstrual 
cycle should be taken into consideration. 
Clearly, there is no unifying concept of adhesion formation. The mechanisms of 
adhesion formation post-operatively, in inflammation and in endometriosis are 
apparently different. 
Our data justify the introduction of t-PA as an experimental medicine in clinical 
adhesion prevention. 
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SAMENVATTING 
In Hoofdstuk 1 wordt de geschiedenis van het onderzoek naar de Pathogenese en de 
preventie van intraperitoneale adhesics beschreven. De conclusie is dat, ondanks de enorme 
hoeveelheid literatuur over adhesies, de oorzaken van het ontstaan van adhesies nog lang niet 
bekend zijn en het nog steeds niet mogelijk is het ontstaan van adhesies te voorkómen. De 
doelstellingen en de opzet van het proefschrift worden uiteengezet. 
In Hoofdstuk 2 worden de prevalentie van intraperitoneale adhesies en de relatie 
tussen adhesies en pijn, ileus en infertiliteit beschreven. De literatuur met betrekking tot de 
Pathogenese van adhesies wordt besproken. Tot slot wordt een overzicht gegeven van de 
fibrinolyse en van enkele bepalingsmethoden betreffende de fibrinoiyse. 
In Hoofdstuk 3 wordt een overzicht gegeven van de literatuur aangaande de preventie 
van adhesies. De verschillende methoden van adhesie preventie worden besproken: het 
beperken van beschadiging van peritoneum, het onderdrukken van de onstekingsreaktie, het 
voorkómen van omzetting van fibrinogeen in fibrine, het afbreken van fibrine en het 
mechanisch afschermen van beschadigde peritoneum oppervlakken. 
In Hoofdstuk 4 wordt onderzoek beschreven naar de verschillen in fibrinolytische 
aktiviteit in peritoneum vloeistof en plasma tussen de eerste en tweede helft van de 
menstruele cyclus. Parameters van de fibrinolyse in peritoneum vloeistof en plasma werden 
gemeten bij acht vrouwen in de pre-ovulatoire en bij elf vrouwen in de post-ovulatoire 
periode van de menstruele cyclus. 
Behalve voor wat betreft PAI-Ag, TDP en FbDP, werden er geen verschillen in 
fibrinolytische parameters tussen de pre- en post-ovulatoire groep gevonden. De concentraties 
van PAI-1-Ag, TDP en FbDP in peritoneum vloeistof waren een faktor drie verhoogd in de 
post-ovulatoire groep (p <0.05). In plasma waren u-PA-Ag en scu-PA significant lager (30%, 
ρ < 0.05) in de post-ovulatoire periode en ook lager dan de plasma spiegels van u-PA-Ag en 
scu-PA (gemeten met dezelfde bepalingsmethoden) in een groep van 50 gezonde mannen en 
vrouwen. 
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De conclusie was dat tijdens de tweede helft van de menstruele cyclus de 
intraperitoneale fibrinolytische capaciteit verminderd is, met een verhoogde kans op het 
ontstaan van adhesies tijdens de post-ovulatoire periode tot gevolg. De verlaagde plasma 
spiegels van u-PA-Ag en scu-PA kunnen klinische betekenis hebben. 
Hoofdstuk 5 beschrijft de fibrinolytische parameters in peritoneum vloeistof en 
plasma bij 10 vrouwen met adnexitis (PID). De controle groep werd gevormd door negen 
vrouwen, die een laparoscopische sterilisatie ondergingen. 
In peritoneum vloeistof van de groep van vrouwen met adnexitis waren de 
concentraties van Ρ AI-Ag, t-PA-Ag en u-PA-Ag vele malen hoger dan in de controle groep. 
Er waren geen significante verschillen tussen de twee groepen voor wat betreft de t-PA 
aktiviteit en het door piasmine activeerbare scu-PA, terwijl tcu-PA niet meetbaar was. De 
gemiddelde concentraties in peritoneum vloeistof van TDP en FbDP waren niettemin twintig 
maal hoger in de adnexitis groep in vergelijk met de controle groep. In plasma waren de 
concentraties van de fibrinolytische parameters in de twee groepen gelijk, behalve voor wat 
betreft u-PA-Ag. 
De conclusie van deze gegevens is dat tijdens adnexitis de intraperitoneale fibrinolyse 
toegenomen is door stimulatie van de lokale produktie van t-PA en u-ΡΑ. Dit is in 
tegenspraak met het klassieke concept van adhesie vorming, dat ervan uitgaat dat adhesies 
ontstaan door een afname van de fibrinolytische aktiviteit. Ondanks de hoge PAI spiegels is 
er sprake van een duidelijke fibrinolyse getuige de hoge concentraties van fibrine afbraak 
Produkten. Omdat de toegenomen fibrinolyse kennelijk niet aan de vraag voldoet, moet een 
medicamenteuze toename van de fibrinolyse overwogen worden om hiermee de vorming van 
adhesies te voorkómen. 
In Hoofdstuk 6 wordt verslag gedaan van onderzoek naar de fibrinolytische 
parameters in peritoneum vloeistof en plasma van tien vrouwen met endometriose. De 
controle groep bestond uit acht vrouwen, bij wie een laparoscopische sterilisatie werd 
verricht. 
In de peritoneum vloeistof van vrouwen met endometriose was t-PA-Act verhoogd 
t.o.v. de controle groep (p<0.05), Ρ AI-Act was verlaagd (61.5%). Er werden geen 
verschillen betreffende de andere fibrinolytische parameters in peritoneum vloeistof 
gevonden. In plasma waren er evenmin verschillen. 
De verhoogde t-PA-Act in peritoneum vloeistof kan het gevolg zijn van fibrinolytische 
aktiviteit van het endometrium, de ectopische endometriose haardjes en/of versleept 
endometrium. De verhoogde t-PA-Act correspondeert niet met het klassieke concept van 
adhesie vorming. 
In Hoofdstuk 7 wordt het voorkómen van postoperatieve adhesie vorming bij het 
konijn door lokale toediening van t-PA onderzocht. Adhesies werden gevormd door het 
peritoneum van de uterus hoornen uit te drogen en door een kleine hoeveelheid bloed in de 
buikholte achter te laten. Bij een groep van konijnen werd t-PA voor het einde van de 
operatie in de buikholte achtergelaten, de andere groep van konijnen vormde de controle 
groep. Elke groep bestond uit 24 konijnen. Na 3 uur en na 1, 3 en 7 dagen vond bij telkens 
6 konijnen een tweede laparotomie plaats en werd de adhaesievorming geëvalueerd. Bij alle 
konijnen in de controle groep kwamen adhesies voor. De adheaesies van de konijnen van de 
t-PA groep waren minder uitgebreid. De conclusie van het onderzoek was, dat het mogelijk 
is de vorming adhesies te voorkómen door na chirurgische ingrepen t-PA in de buikholte 
achter te laten. 
In Hoofdstuk 8 wordt een onderzoek beschreven naar de mesotheel genezing met en 
zonder toegediend t-PA. Voorts werd het ontstaan van nieuw mesotheel beschreven. 
Beschadiging van mesotheel en de vorming van adhesies kwamen tot stand door het 
mesotheel uit te drogen en door een kleine hoeveelheid bloed in de buikholte achter te laten. 
T-PA had geen nadelige invloed op de genezing van mesotheel; zowel in de t-PA- als 
in de controle groep was de genezing van mesotheel voltooid na zeven dagen. De weefsel 
reaktie in de t-PA groep was geringer in vergelijk met de controle groep. 
Door middel van licht microscopisch en immunohistochemisch onderzoek werd 
aangetoond dat er een proliferatie van fibroblastoide cellen ontstond in de submesotheliale 
weefsels en op het wondoppervlak. Deze cellen vertoonden elektronenmicroscopisch 
eigenschappen van mesotheliale cellen. De eigenschappen en de lokatie doen vermoeden dat 
de fibroblastoide cellen de voorlopers zijn van mesotheel cellen. 
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In Hoofdstuk 9 worden de conclusies van ons onderzoek besproken: 
Er zijn aanwijzingen dat de kans op het ontstaan van adhesies in de tweede helft van 
de menstruele cyclus vergroot is. 
Bij de interpretatie van u-ΡΑ spiegels in plasma van vrouwen moet fase van de 
menstruele cyclus betrokken worden. 
Er is geen eenduidig concept betreffende de vorming van adhesies. De wijze waarop 
adhesies ontstaan na operaties, ten gevolge van ontstekingen en bij endometriose is 
verschillend. 
Op grond van de resultaten van ons onderzoek is het gebruik van t-PA in een klinisch 
onderzoek gerechtvaardigd. 
DANKWOORD 
Het onderzoek van deze dissertatie werd uitgevoerd binnen het Instituut voor Obstetrie 
en Gynaecologie van het St. Radboud Ziekenhuis (hoofd: Prof. Dr. Т.К.A.B. Eskes / Prof. 
Dr. R. Rolland) en het Centraal Dierenlaboratorium van de Katholieke Universiteit (hoofd 
destijds: Prof. Dr. W.G. van der Gulden) in Nijmegen, het Gaubius Instituut TNO 
(direkteur: Prof. Dr. P. Brakman), nu onderdeel van het Gaubius Laboratory IVVO-TNO 
(direkteur: Prof. Dr. D. Knook) in Leiden, en de afdelingen Pathologie en Verloskunde-
Gynaecologie van het Westeinde Ziekenhuis in Den Haag. 
Dit proefschrift kwam tot stand met hulp en medewerking van velen. Dit geldt in de 
eerste plaats voor de promotoren en mede-auteurs van de artikelen, die dit proefschrift 
vormen. Van hen in het bijzonder heb ik veel geleerd, waarvoor ik ze veel dank verschuldigd 
ben. 
De volgende personen wil ik met name noemen en bedanken: 
Prof. Dr. Hans Vemer, die niet alleen dit onderzoek met veel enthousiasme heeft 
begeleidde, maar mij ook anderszins met raad en daad terzijde heeft gestaan. 
Prof. Dr. Rune Rolland, die nauw betrokken was bij de start van dit ondezoek en 
vervolgens mij vooral met de laatste fase ervan heeft geholpen. 
Dr. Emile Brommer, die wel een zeer belangrijke bijdrage heeft geleverd bij het tot 
stand komen van dit proefschrift. Zijn manier van wetenschappelijk denken is van grote 
invloed op mij geweest. 
De medewerkers van het laboratorium van het Gaubius Instituut in Leiden, het 
laboratorium van het Instituut voor Obstetrie en Gynaecologie van het Sint Radboud 
Ziekenhuis en de laboratoria voor Klininische Chemie en Pathologie van het Westeinde 
Ziekenhuis voor het verwerken van de plasma en serum monsters, het uitvoeren van 
bepalingen en het maken van de coupes. 
Theo Arts, Fred Philipsen en Ton Peters, medewerkers van het Centraal 
Dierenlaboratorium, voor hun assistentie bij het opereren van de konijnen. 
Mevrouw S.A.M, van Haastert en Nicolien van den Brûle, bibliothekaresses van de 
Medische Bibliotheek van het Westeinde Ziekenhuis. 
123 
Mevrouw Josephine Say voor de Engelse correcties van het manuscript. 
Dr. Ir. P.L. Arens, mijn schoonvader, voor het kritisch lezen van het manuscript en 
zijn "Wageningse" kijk op de medische wetenschap. 
Mijn maten Dr. Frans Kok en Drs. Jan Lind, die mij de gelegenheid boden onderzoek 
te doen en het manuscript te schrijven. 
De vrouwen, die peritoneumvl oei stof en bloed ter beschikking stelden voor het 
onderzoek. 
CURRICULUM VITAE 
Petrus Johannes Dörr 
1951 Geboren in Hilversum 
1969 Eindexamen Gymnasium β, Comenius College te Hilversum 
1977 Artsexamen Vrije Universiteit te Amsterdam 
1977-1980 B-opleiding gynaecologie Ziekenhuis Ziekenzorg te Enschede (opleider 
dr. K.J.H. Verschoof) 
1980-1981 A-opleiding gynaecologie Canisius-Wilhelmina Ziekenhuis te Nijmegen 
(opleider dr. A.J.J. de Bruin) 
1981-1982 A-opleiding gynaecologie St. Radboud Ziekenhuis te Nijmegen 
(opleiders prof. dr. J.L. Mastboom, prof. dr. Т.К.A.B. Eskes) 
1978 Huwelijk met Irène Arens 
1981 Geboorte Laura 
1982 Geboorte Pedro 
1983 Geboorte Marieke 
1983-1984 "junior-gynaecoloog" Canisius-Wilhelmina Ziekenhuis te Nijmegen 
1984-1987 chef de clinique Westeinde Ziekenhuis te Den Haag 
1987-heden gynaecoloog Westeinde Ziekenhuis te Den Haag 
125 

STELLINGEN 
behorende bij het proefschrift 
"Adhesions and Fibrinolysis*1 
PJ. Dörr 
1. Er is geen eenduidig concept betreffende de vorming van adhesies. De wijze waarop 
adhesies ontstaan is verschillend: na operaties, ten gevolge van on stekingen en bij 
endometriose. (dit proefschrift) 
2. De relatie tussen adhesies en pijn is minder duidelijk dan vaak door dokter en patiënt 
wordt aangenomen. (dit proefschrift) 
3. Bij vrouwen met adnexitis is de intraperitoneale fibrinolytische aktiviteit toegenomen, 
maar kennelijk onvoldoende om adhesies te voorkomen. (dit proefschrift) 
4. De verhoogde fibrinolytische aktiviteit in de peritoneum vloeistof bij vrouwen met 
endometriose past goed bij de transplantatie theorie als oorzaak van endometriose. 
(dit proefschrift) 
5. De diagnose adnexitis dient door de gynaecoloog gesteld te worden. 
6. Wetenschappelijk onderzoek behoort een belangrijk onderdeel te zijn van de opleiding 
van arts-assistenten, niet alleen in het belang van henzelf maar ook in het belang van 
de ontwikkeling van de verloskunde en gynaecologie op langere termijn (naar: 
Thomas E. Br J Obstet Gynaecol 1993; 100: 35-36). 
7. De management funktie van de medisch specialist verdient een plaats in de opleiding 
van arts-assistenten. 
8. Promoveren voorkomt beklemd titelloos wakker worden (naar: Wim Kan). 
9. De huidige aandacht en inspanningen voor het verbeteren van het materiële leefmilieu 
houdt geen gelijke tred met hoognodige inspanningen voor het beter maken van het 
geestelijk leefmilieu in onze samenleving. 
10. Voorzover de financiële belangen van ziekenhuizen en die van de gezondheidszorg 
in het algemeen strijdig zijn, dient deze tegenstelling te verdwijnen. 
11. De honorering van medisch specialisten dient gebaseerd te zijn op een uurtarief, en 
verder afhankelijk te zijn van het aantal patiënten dat door de specialist behandeld 
wordt en van de "disutility" voor het desbetreffende specialisme. 
12. Stellingen bij een proefschrift moeten een aanvechtbaar karakter hebben. Het lanceren 
van niet aanvechtbare spitsvondigheden als stellingen moet worden tegengegaan. 
Nijmegen, 1 juli 1993 

